<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS201156</article-id><article-id pub-id-type="doi">10.1101/2024.11.23.624991</article-id><article-id pub-id-type="archive">PPR945046</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">2</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Diverse phage defence systems define West African South American pandemic <italic>Vibrio cholerae</italic></article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Adams</surname><given-names>David W.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Jaskólska</surname><given-names>Milena</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lemopoulos</surname><given-names>Alexandre</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Stutzmann</surname><given-names>Sandrine</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Righi</surname><given-names>Laurie</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bader</surname><given-names>Loriane</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Blokesch</surname><given-names>Melanie</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Laboratory of Molecular Microbiology, Global Health Institute, School of Life Sciences, Station 19, EPFL-SV-UPBLO, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02s376052</institution-id><institution>Ecole Polytechnique Fédérale de Lausanne (EPFL)</institution></institution-wrap>, <postal-code>CH-1015</postal-code><city>Lausanne</city>, <country country="CH">Switzerland</country></aff><author-notes><corresp id="CR1"><label>*</label>Corresponding authors: <email>david.adams@epfl.ch</email> and <email>melanie.blokesch@epfl.ch</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>26</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>24</day><month>11</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">CC BY-ND 4.0 International license</ext-link>.</license-p></license><license><ali:license_ref>https://europepmc.org/downloads/openaccess</ali:license_ref><license-p>This preprint is made available via the <ext-link ext-link-type="uri" xlink:href="https://europepmc.org/downloads/openaccess">Europe PMC open access subset</ext-link>, for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original preprint source.</license-p></license></permissions><abstract><title>Summary</title><p id="P1">Our understanding of the factors underlying the evolutionary success of different lineages of pandemic <italic>Vibrio cholerae</italic> remains incomplete. Interestingly, two unique genetic signatures define the West African South American (WASA) lineage of <italic>V. cholerae</italic> responsible for the 1991-2001 Latin American cholera epidemic. Here we show these signatures encode diverse anti-phage defence systems. Firstly, the WASA-1 prophage encodes a 2-gene abortive-infection system WonAB that renders the lineage resistant to the major predatory vibriophage ICP1, which alongside other phages, is thought to restrict cholera epidemics and has potential for use in prophylaxis. Secondly, a unique set of genes on the <italic>Vibrio</italic> seventh pandemic island II encodes an unusual modification-dependent restriction system targeting phages with modified genomes, and a new member of the Shedu defence family that defends against vibriophage X29. Taken together, we propose that these anti-phage defence systems have likely contributed to the success of a major epidemic lineage of the ongoing seventh cholera pandemic.</p></abstract></article-meta></front><body><p id="P2">The ability of lytic bacteriophages to rapidly devastate bacterial populations has driven the evolution of multiple layers of defence, including a diverse array of specialised anti-phage defence systems<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. Bacteriophages also have the potential to affect bacterial pathogenesis, as exemplified by the cholera toxin-encoding prophage CTXΦ<sup><xref ref-type="bibr" rid="R2">2</xref></sup>. Moreover, bacteriophage predation is thought to limit the duration and severity of cholera epidemics, as well as affecting individual patient outcomes<sup><xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R6">6</xref></sup>. Sampling of cholera patients has revealed that the O1 El Tor strains of <italic>Vibrio cholerae</italic> responsible for the ongoing seventh cholera pandemic (7PET) consistently co-occur with three lytic phages ICP1, 2 and 3, with ICP1 being most frequently isolated<sup><xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R8">8</xref></sup>. Furthermore, the demonstration that a cocktail of ICP1-2-3 can prevent cholera in animal infection models has led to renewed interest in using phages as a prophylactic treatment<sup><xref ref-type="bibr" rid="R9">9</xref></sup>. There is therefore an urgent need to understand the mechanisms by which <italic>V. cholerae</italic> defends against these and other viruses.</p><p id="P3">Since 1961 7PET strains have spread out from the Bay of Bengal in a series of three distinct but overlapping waves<sup><xref ref-type="bibr" rid="R10">10</xref></sup>. Importantly, from Wave 2 onwards strains acquired SXT/R391 integrative and conjugative elements (SXT-ICE), which in addition to carrying multiple antibiotic resistance genes, encode a variable anti-phage defence hotspot that in the globally dominant SXT-ICE harbours either BREX or Restriction-Modification systems active against ICP1-3<sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref></sup>. Additionally, a family of viral satellites, the Phage-inducible chromosomal island-like elements (PLE), also occur sporadically and specifically parasitise ICP1 infection to mediate their own transmission<sup><xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref></sup>. Notably, these elements exemplify the co-evolutionary arms race of defence and counter-defence between bacterial hosts and their viral predators, with the emergence of resistant ICP1 phages that can overcome these defence mechanisms selecting for either alternative SXT-ICE carrying new defence systems or new PLE variants<sup><xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R14">14</xref></sup>. In contrast, how 7PET strains that lack SXT-ICE/PLE defend against these phages remains unknown. Given their ubiquitous nature and ability to shape epidemics, we hypothesised that these strains likely contained additional defence systems with activity against ICP1-3.</p><sec id="S1"><title>WASA-1 prophage renders Peruvian strains resistant to ICP1</title><p id="P4">To test this hypothesis, we challenged a set of intensively studied wave 1 strains that lack SXT-ICE/PLE with a well-characterised collection of ICP1-3 phages that utilise the O1-antigen (ICP1/3) and OmpU (ICP2) as receptors<sup><xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R16">16</xref></sup>. All strains exhibited the expected sensitivities to ICP2 and ICP3 (<xref ref-type="fig" rid="F1">Fig. 1a</xref> and <xref ref-type="fig" rid="F6">Extended Data Fig. 1a-b</xref>). Unexpectedly, however, the widely used model strain A1552 – a Peruvian isolate – was completely resistant to all 16 tested ICP1 isolates spanning a twenty-seven-year period, including the most recent isolates from the Democratic Republic of the Congo<sup><xref ref-type="bibr" rid="R17">17</xref></sup>, displaying a 10<sup>5</sup>-fold reduction in plaque formation (<xref ref-type="fig" rid="F1">Fig. 1a</xref> and <xref ref-type="fig" rid="F6">Extended Data Fig. 1a-e</xref>). Notably, the contemporary Peruvian strains C6706 and C6709 also behaved similarly. Interestingly, although zones of lysis were still observed at the highest concentrations of phage tested, re-streak tests revealed that these spots contained little-to-no viable particles (<xref ref-type="fig" rid="F6">Extended Data Fig. 1c</xref>), suggesting that ICP1 propagation is significantly impaired and that these lysis zones represent ‘lysis from without’<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. Indeed, liquid replication assays comparing A1552 with the non-Peruvian strain E7946, showed that although genome injection proceeded similarly in both strains, in contrast to the robust replication observed with E7946, ICP1 was completely unable to replicate on strain A1552 (<xref ref-type="fig" rid="F6">Extended Data Fig. 1d</xref>). ICP1 resistance in strain A1552 was independent of the <italic>Vibrio</italic> pathogenicity islands (VPI-1/2) and the <italic>Vibrio</italic> seventh pandemic islands (VSP-I/II), which together harbour multiple known anti-viral defence systems<sup><xref ref-type="bibr" rid="R19">19</xref>–<xref ref-type="bibr" rid="R26">26</xref></sup> (<xref ref-type="fig" rid="F6">Extended Data Fig. 1e</xref>). Moreover, the ICP1-resistant strains encode the same repertoire of known defence systems as the ICP1-sensitive strains (<xref ref-type="supplementary-material" rid="SD4">Supplementary Table 1</xref>), suggesting that a novel as yet unrecognised defence system(s) is likely responsible for ICP1 resistance.</p><p id="P5">The Peruvian strains are members of the West African South American (WASA) lineage of 7PET <italic>V. cholerae</italic><sup><xref ref-type="bibr" rid="R10">10</xref></sup>, which was responsible for a massive cholera epidemic that started in Peru in 1991, before spreading rapidly throughout Latin America, resulting in over 1.2 million cholera cases and approximately 12,000 deaths<sup><xref ref-type="bibr" rid="R27">27</xref></sup>. Interestingly, phylogenetic analysis has shown that these strains originated in West Africa, where they acquired two genetic signatures that define the WASA lineage: (i) a novel set of genes on VSP-II and (ii) the WASA-1 prophage<sup>10,28-31</sup>. Since deletion of VSP-II had no effect on ICP1 resistance we tested strains deleted for WASA-1. Strikingly, this abolished defence against ICP1 in all tested Peruvian strains, and restored ICP1 replication to levels similar to those of a susceptible control (<xref ref-type="fig" rid="F1">Fig. 1b-e</xref> and <xref ref-type="fig" rid="F6">Extended Data Fig. 1b</xref>). Moreover, introducing WASA-1 into non-WASA lineage strains rendered them ICP1 resistant (<xref ref-type="fig" rid="F6">Extended Data Fig. 1f</xref>).</p><sec id="S2"><title>WonAB system is responsible for ICP1 defence</title><p id="P6">The WASA-1 prophage is highly conserved throughout all WASA lineage strains<sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R30">30</xref></sup>, and interestingly, is also found in diverse <italic>Vibrio</italic> species (<xref ref-type="fig" rid="F1">Fig. 1b</xref>, <xref ref-type="fig" rid="F7">Extended Data Fig. 2a</xref> and <xref ref-type="supplementary-material" rid="SD5">Supplementary Table 2</xref>). WASA-1 displays a conserved core genome encoding proteins involved in capsid/tail biogenesis, DNA replication and a recombinase (<xref ref-type="fig" rid="F1">Fig. 1b</xref>). To determine the gene(s) responsible for ICP1 defence, we used an existing RNA-seq dataset<sup><xref ref-type="bibr" rid="R32">32</xref></sup> to identify WASA-1 genes expressed under laboratory conditions, and then screened truncations of these regions for loss of protection (<xref ref-type="fig" rid="F7">Extended Data Fig. 2b</xref>). This revealed a 2-gene operon (A1552VC_01233-34) encoding an ATPase and a hypothetical protein, downstream of a conserved putative transcriptional regulator (A1552VC_01232) (<xref ref-type="fig" rid="F1">Fig. 1b</xref>). For the reasons outlined below we have renamed this operon <underline>W</underline>ASA <underline>O</underline>LD-ABC ATPase <underline>N</underline>uclease, WonAB. Strikingly, deletion of <italic>wonAB</italic> abolished protection against ICP1. Moreover, ectopic expression of <italic>wonAB</italic> complemented the Δ<italic>wonAB</italic> deletion and conferred complete protection to ICP1-sensitive non-WASA strains (<xref ref-type="fig" rid="F1">Fig. 1d-e</xref>). Importantly, both genes were required for protection indicating that production of WonAB is both necessary and sufficient for anti-phage activity (<xref ref-type="fig" rid="F1">Fig. 1f</xref>). Notably, although WonAB is unique to the WASA-1 prophage found in <italic>V. cholerae</italic>, known defence systems could also be found at the same locus in other non-cholerae WASA-1 (<xref ref-type="supplementary-material" rid="SD5">Supplementary Table 2</xref>), consistent with the observation that prophages often carry anti-phage defence systems to increase the fitness of their bacterial hosts<sup><xref ref-type="bibr" rid="R33">33</xref>–<xref ref-type="bibr" rid="R35">35</xref></sup>.</p><p id="P7">Bioinformatic analysis revealed that WonA is an ATP-binding cassette (ABC) ATPase with a predicted core β-barrel like ATPase fold characteristic of the ABC-ATPase clade<sup><xref ref-type="bibr" rid="R36">36</xref></sup>. Motifs required for ATP binding and hydrolysis (Walker A, Q-loop, ABC-signature, Walker B, D-loop and H-loop) were readily identifiable (<xref ref-type="fig" rid="F1">Fig. 1g</xref> and <xref ref-type="fig" rid="F8">Extended Data Fig. 3a</xref>). Moreover, structural modelling confidently predicted that WonA forms a dimer, in which these motifs are positioned at the dimer interface to form the composite ATP-binding sites typical of ABC-ATPases<sup><xref ref-type="bibr" rid="R36">36</xref></sup> (<xref ref-type="fig" rid="F1">Fig. 1g</xref>, <xref ref-type="fig" rid="F8">Extended Data Figs. 3b</xref> and <xref ref-type="fig" rid="F4">4a-b</xref>). In contrast, WonB is predicted to encode a variant of the PD-(D/E)xK nuclease fold, with the highly conserved active site residues clustered together<sup><xref ref-type="bibr" rid="R37">37</xref></sup> (<xref ref-type="fig" rid="F1">Fig. 1g</xref> and <xref ref-type="fig" rid="F8">Extended Data Fig. 3c-d</xref>). Variants designed to disrupt either WonA ATP-binding/hydrolysis (K34A; R182A; E300A; H333A) or WonB nuclease activity (K71A) all abolished protection against ICP1, despite mostly being produced at similar levels to the WT control (<xref ref-type="fig" rid="F1">Fig. 1h</xref> and <xref ref-type="fig" rid="F8">Extended Data Fig. 3e</xref>). Interestingly, Western blotting showed that inactivating WonA ATPase activity resulted in the loss of WonB, suggesting that WonA regulates or otherwise affects the stability of WonB (<xref ref-type="fig" rid="F8">Extended Data Fig. 3e</xref>). Indeed, the two proteins are predicted to form a complex, with WonB binding to a surface created by the dimerised C-terminal extensions of WonA (<xref ref-type="fig" rid="F1">Fig. 1g</xref> and <xref ref-type="fig" rid="F9">Extended Data Fig. 4a-d</xref>).</p><p id="P8">Homologues of WonAB are found in diverse classes of mainly Gram-negative bacteria and overall were present in 0.43% of bacterial genomes examined (<xref ref-type="fig" rid="F8">Extended Data Fig. 3f</xref> and <xref ref-type="supplementary-material" rid="SD6">Supplementary Table 3</xref>). Notably, when expressed in <italic>Escherichia coli</italic> WonAB displayed robust activity against all members of the <italic>Vequintavirinae</italic> subfamily of the BASEL bacteriophage collection<sup><xref ref-type="bibr" rid="R38">38</xref></sup>, indicating that WonAB activity is not limited to ICP1 (<xref ref-type="fig" rid="F10">Extended Data Fig. 5</xref>). Interestingly, WonA ATPase motifs display deviations typical of the overcoming lysogenisation defect (OLD) family of ABC-ATPases<sup><xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R39">39</xref></sup> (<xref ref-type="fig" rid="F8">Extended Data Fig. 3a</xref>). However, members of this family such as OLD, Gabija, PARIS and the related Septu, are distinct from WonA in both structure and domain composition<sup><xref ref-type="bibr" rid="R39">39</xref>–<xref ref-type="bibr" rid="R44">44</xref></sup>. In contrast, WonAB appears to be closely related to an operon encoding a predicted OLD-ABC ATPase and a novel version of the restriction-enzyme fold (<xref ref-type="fig" rid="F9">Extended Data Fig. 4</xref>), detected during a recent comprehensive <italic>in silico</italic> survey of ABC-ATPases<sup><xref ref-type="bibr" rid="R36">36</xref></sup>. Moreover, homologues of this operon are found in 0.96% of bacterial genomes and encompass all detected homologues of WonAB (<xref ref-type="supplementary-material" rid="SD6">Supplementary Table 3</xref>). Furthermore, WonAB also shows similarity to operons with a similar organisation such as PD-T4-4 that have also recently been identified (<xref ref-type="fig" rid="F9">Extended Data Fig. 4</xref>), albeit with variations in the Insert 1/2 regions and C-terminal extensions of the ATPase, and in some cases a distinct nuclease<sup><xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R45">45</xref></sup>. Taken together, these data suggest that WonAB is part of a larger as yet uncharacterised family of ABC-ATPase sensors that are paired with nuclease effectors.</p></sec><sec id="S3"><title>ICP1 defence occurs via lysis-independent abortive infection</title><p id="P9">To gain insights into how WonAB mediates ICP1 defence we monitored the growth kinetics of ICP1-infected cells at different multiplicities of infection (MOI), in the absence and presence of WASA-1 (<xref ref-type="fig" rid="F2">Fig. 2a</xref>). This revealed that WonAB provides robust protection against ICP1 at low MOI when only a subset of cells is initially infected. In contrast, infection at high MOI, when most cells are simultaneously infected, resulted in a growth arrest (<xref ref-type="fig" rid="F2">Fig. 2a</xref>). This phenotype is characteristic of abortive infection, wherein individual cell viability is sacrificed prior to the completion of phage replication to protect the surrounding bacterial population<sup><xref ref-type="bibr" rid="R46">46</xref></sup>. Indeed, time-lapse microscopy showed that while both WT and ΔWASA-1 cells swell upon infection, cells of the ΔWASA-1 go on to lyse within ~20min, whereas WT cells remain in this swollen state without lysing for the 60min duration of the experiment (<xref ref-type="fig" rid="F2">Fig. 2b</xref>, <xref ref-type="fig" rid="F11">Extended Data Fig. 6</xref> and movie 1). Moreover, these non-growing cells persisted in an intact state for several hours before eventually undergoing lysis (<xref ref-type="fig" rid="F12">Extended Data Fig. 7a-b</xref>). During this time ICP1-infected cultures rebounded due to the selection of spontaneous O1-antigen mutants (<xref ref-type="fig" rid="F12">Extended Data Fig. 7c</xref>), as has been previously described<sup><xref ref-type="bibr" rid="R7">7</xref></sup>. Importantly, this is likely an <italic>in vitro</italic> phenomenon since O1-antigen mutants are attenuated for virulence in animal infection models<sup><xref ref-type="bibr" rid="R47">47</xref></sup>.</p><p id="P10">Efforts to isolate either a spontaneous or an evolved ICP1 escape mutant able to overcome WonAB have so far proved unsuccessful. Therefore, to study the mode of action of WonAB in more detail we investigated different stages of the ICP1 lifecycle in the absence and presence of WASA-1<sup><xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R48">48</xref></sup>. First, quantitative-PCR showed that ICP1 DNA replication proceeds similarly in both strain backgrounds, albeit with a 2.7-fold defect in the WT background, indicating that WonAB neither restricts ICP1 DNA on entry nor prevents the initiation of DNA replication (<xref ref-type="fig" rid="F2">Fig. 2c</xref>). Second, microscopy revealed that upon infection the nucleoids of both strains undergo dramatic changes in morphology by 4min post-infection, with the nucleoid frequently appearing to contract along its long axis, likely representing the action of ICP1-encoded nucleases and host-cell takeover<sup><xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R49">49</xref></sup> (<xref ref-type="fig" rid="F2">Fig. 2d</xref>). Notably, whereas ΔWASA-1 cells then rapidly went on to lyse, DNA in WT cells persisted in a highly compacted state and went on to form toroidal structures, suggesting that WonAB does not act by simply degrading DNA. Third, microscopy of ICP1-infected cells producing a fluorescent protein fusion to the ICP1 major capsid protein revealed robust capsid assembly, lysis and release in the ΔWASA-1 background (<xref ref-type="fig" rid="F2">Fig. 2e-g</xref>). In contrast, capsid assembly was largely absent in WT cells (<xref ref-type="fig" rid="F2">Fig. 2f</xref>). Taken together, these results show that WonAB does not prevent the initial damage inflicted by ICP1, and suggest that WonAB is activated after the initiation of ICP1 DNA replication and prevents progression to structural protein assembly.</p></sec><sec id="S4"><title>WonAB activation shuts down cell growth by inhibiting translation</title><p id="P11">The data so far are consistent with WonAB aborting ICP1 infection via a lysis-independent mechanism that targets the host cell. To test whether WonAB can be artificially activated in the absence of infection, we overexpressed either the <italic>wonAB</italic> operon or each gene individually in an otherwise WT background (<xref ref-type="fig" rid="F3">Fig. 3a</xref> and <xref ref-type="fig" rid="F13">Extended Data Fig. 8a</xref>). While <italic>wonAB</italic> and <italic>wonA</italic> had no apparent phenotype, WonB overproduction was highly toxic, resulting in a growth arrest and a rapid loss in viability, with &gt;99% of cells non-viable within 30min (<xref ref-type="fig" rid="F3">Fig. 3a-c</xref> and <xref ref-type="fig" rid="F13">Extended Data Fig. 8a</xref>). Furthermore, toxicity was dependent on WonB nuclease activity since the WonB[K71A] variant was non-toxic (<xref ref-type="fig" rid="F3">Fig. 3b-c</xref> and <xref ref-type="fig" rid="F13">Extended Data Fig. 8a</xref>). One explanation for these data could be that WonAB is a toxin-antitoxin system, with WonA acting as an antitoxin to neutralise the toxicity of WonB<sup><xref ref-type="bibr" rid="R50">50</xref></sup>. Indeed, the DarTG toxin-antitoxin system has recently been shown to have activity against ICP1<sup><xref ref-type="bibr" rid="R51">51</xref></sup>. Arguing against this hypothesis, however, WonB overproduction was not toxic in a Δ<italic>wonAB</italic> background, despite being produced at similar levels to the control (<xref ref-type="fig" rid="F3">Fig. 3a</xref> and <xref ref-type="fig" rid="F13">Extended Data Fig. 8b-c</xref>). Moreover, deletion of <italic>wonA</italic> or inactivation of WonA ATPase activity also abolished the toxicity associated with WonB overproduction (<xref ref-type="fig" rid="F3">Fig. 3a</xref> and <xref ref-type="fig" rid="F13">Extended Data Fig. 8b-c</xref>). Thus, these results rule out a simple sequestration mechanism and suggest that WonA is either required to activate WonB or that the two proteins act together.</p><p id="P12">Microscopy revealed that following WonB overproduction growth-arrested cells exhibit condensed nucleoids that at later stages display aberrant morphologies and are highly compacted (<xref ref-type="fig" rid="F3">Fig. 3d</xref> and <xref ref-type="fig" rid="F13">Extended Data Fig. 8d</xref>). Notably, the vast majority of cells retained DNA and purified genomic DNA also remained intact (<xref ref-type="fig" rid="F13">Extended Data Fig. 8d-e</xref>), indicating that toxicity does not result from chromosomal DNA degradation. Since the nucleoid compaction phenotype resembled the effects of antibiotics that inhibit translation<sup><xref ref-type="bibr" rid="R52">52</xref></sup>, we investigated WonB production over time using Western blotting (<xref ref-type="fig" rid="F3">Fig. 3e</xref>). Remarkably, this revealed that compared to the inactivated WonB[K71A] control, WonB is produced only for short time after induction, and by 30min post-induction was no longer detectable. Importantly, qRT-PCR showed that <italic>wonB</italic> mRNA levels were induced similarly between the two constructs and remained stable throughout the course of the experiment (<xref ref-type="fig" rid="F13">Extended Data Fig. 8f</xref>). These data suggested that (i) WonB overproduction inhibits translation and (ii) that WonB is likely unstable. In agreement with these hypotheses, following inhibition of translation with chloramphenicol, WonB rapidly disappeared in a Lon protease-dependent manner (<xref ref-type="fig" rid="F3">Fig. 3f-g</xref>), indicating that WonB is indeed unstable and subject to proteolytic degradation. Since in the absence of ICP1, WonB was toxic only when produced in excess of WonA, Lon-mediated degradation likely functions as a safety mechanism to reduce WonB accumulation and hence prevent auto-immunity. Collectively, these results support a model whereby upon activation WonAB aborts phage infection by inhibiting translation, and thus prevents the progression of the ICP1 lifecycle. Notably, although WonAB aborts the infection, cells are likely already irreversibly damaged by ICP1 during the initial stages of the infection. Furthermore, since the growth-arrest upon WonB overproduction does not result in genomic DNA degradation, these results suggest that the target of WonB nuclease activity could be a rRNA or tRNA.</p></sec><sec id="S5"><title>VSP-II<sup>WASA</sup> carries two distinct anti-phage defence systems</title><p id="P13">The second genetic signature of the WASA lineage is a unique variant of VSP-II (<xref ref-type="fig" rid="F4">Fig. 4a</xref>), wherein the chemotaxis gene cluster from the prototypical VSP-II is replaced by a set of three novel genes (A1552VC_00274-76) and a frame-shifted transposase gene<sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R28">28</xref>,<xref ref-type="bibr" rid="R53">53</xref></sup>. Although these genes are not predicted to be part of a known defence system, and lacked activity against ICP1-3, bioinformatic analysis revealed that they encode proteins with domains characteristic of defence systems (see below). Consistent with this, when this cluster was expressed in <italic>E. coli</italic> we observed anti-phage activity against several major groups of the BASEL collection (<xref ref-type="fig" rid="F4">Fig. 4b</xref> and <xref ref-type="fig" rid="F14">Extended Data Fig. 9a</xref>). As outlined below, genetic dissection revealed that this cluster encodes two independent systems, with the two-gene operon VC_00274-75 encoding the <underline>G</underline>mrSD-like Type IV <underline>R</underline>Ease of <underline>W</underline>ASA strains, GrwAB (<xref ref-type="fig" rid="F4">Fig. 4c-e</xref>) and VC_00276 encoding the <italic><underline>V</underline>. <underline>c</underline></italic><italic>holerae</italic> <underline>S</underline>he<underline>du</underline>, <italic>Vc</italic>SduA (<xref ref-type="fig" rid="F4">Fig. 4f-h</xref>).</p></sec><sec id="S6"><title>GrwAB is a two-component modification-dependent restriction system</title><p id="P14">GrwAB showed potent anti-phage activity against all members of the <italic>Queuovirinae</italic> and <italic>Tevenvirinae</italic> (<italic>Straboviridae</italic>), as well as some members of the <italic>Markadamsvirinae</italic> (<italic>Demerecviridae</italic>), and both genes were required for protection (<xref ref-type="fig" rid="F4">Fig. 4b</xref>). Interestingly, the signature feature of the <italic>Queuovirinae</italic> and <italic>Tevenvirinae</italic> subfamilies is that their genomes contain hypermodified nucleobases with either 7-deazaguanine modified guanosines or sugar-modified hydroxymethyl cytosines, respectively, suggesting that GrwAB may recognise DNA modification<sup><xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R54">54</xref>,<xref ref-type="bibr" rid="R55">55</xref></sup>. In line with this hypothesis, GrwAB resembles the GmrSD family of modification-dependent restriction enzymes, such as GmrSD, BrxU and SspE<sup><xref ref-type="bibr" rid="R56">56</xref>–<xref ref-type="bibr" rid="R59">59</xref></sup> (<xref ref-type="fig" rid="F4">Fig. 4c</xref> and <xref ref-type="fig" rid="F15">Extended Data Fig. 10a-d</xref>). These are typically single protein systems composed of an N-terminal DUF262 domain that likely functions as a DNA modification sensor, and that uses NTP binding/hydrolysis to regulate the activity of a C-terminal His-Me nuclease domain (DUF1524), which functions as an effector to target non-self DNA<sup><xref ref-type="bibr" rid="R56">56</xref>,<xref ref-type="bibr" rid="R58">58</xref>,<xref ref-type="bibr" rid="R60">60</xref></sup>. Indeed, GrwA is predicted to share this architecture, with an N-terminal DUF262 domain containing the highly conserved QR, DGQQR and FxxN motifs<sup><xref ref-type="bibr" rid="R56">56</xref></sup>, coupled by an α-helical linker to a C-terminal DUF1524 domain containing the canonical ββα fold and catalytic residues of the His-Me nuclease superfamily<sup><xref ref-type="bibr" rid="R61">61</xref></sup> (<xref ref-type="fig" rid="F4">Fig. 4c</xref> and <xref ref-type="fig" rid="F15">Extended Data Fig. 10a-c</xref>). In contrast, and unlike known GmrSD systems, GrwB encoded by the second gene contains an N-terminal DUF262 domain followed by multiple domains of unknown function (<xref ref-type="fig" rid="F4">Fig. 4c</xref> and <xref ref-type="fig" rid="F15">Extended Data Fig. 10d</xref>). Notably, variants designed to disrupt either the NTP hydrolysis of DUF262 in GrwA[R81A] and GrwB[R86A], or the nuclease activity of DUF1524 in GrwA[H431A]/[N521A/[N530A] all abolished anti-phage activity (<xref ref-type="fig" rid="F4">Fig. 4d</xref>), indicating that GrwA and GrwB function together. Indeed, structural modelling of a potential GrwAB complex supports the idea that the two proteins interact (<xref ref-type="fig" rid="F15">Extended Data Fig. 10e</xref>).</p><p id="P15">Importantly, multiple independent escaper mutants of Bas24 were obtained that overcome defence by GrwAB (<xref ref-type="fig" rid="F16">Extended Data Fig. 11a</xref>). These escapers all contain changes in either the active site or the DNA-binding surface of DpdA – the transglycosylase that inserts the 7-deazaguanine modification into the DNA – consistent with the disruption of DNA modification leading to immune evasion<sup><xref ref-type="bibr" rid="R62">62</xref></sup> (<xref ref-type="fig" rid="F16">Extended Data Fig. 11b-d</xref>). Interestingly, growth kinetics of phage-infected cultures producing GrwAB lacked the growth arrest or premature lysis typical of abortive infection (<xref ref-type="fig" rid="F4">Fig. 4e</xref>). However, cultures did go on to exhibit moderate-to-severe lysis, which microscopy revealed was due to the presence of non-dividing filamentous cells (<xref ref-type="fig" rid="F17">Extended Data Fig. 12</xref> and movie 2), suggesting that either GrwAB is unable to clear the infection prior to the cell sustaining irreversible damage or that the cell is subject to collateral damage during phage defence. Finally, bioinformatic analyses revealed that homologues of GrwAB are found in ~1% of genomes examined (<xref ref-type="fig" rid="F15">Extended Data Fig. 10f</xref> and <xref ref-type="supplementary-material" rid="SD7">Supplementary Table 4</xref>), suggesting that GrwAB represents a new member of an emerging family of two-gene GmrSD-like modification-dependent restriction enzymes that includes the recently discovered TgvAB system present in <italic>V. cholerae</italic> VPI-2<sup><xref ref-type="bibr" rid="R25">25</xref>,<xref ref-type="bibr" rid="R26">26</xref></sup>. Similar to TgvAB, the requirement for both GrwA and GrwB suggests that these proteins likely act as a complex, which could represent either a novel mode of action or else a mechanism to overcome phage-encoded anti-defences. Notably, despite the similarities, GrwAB has an expanded range compared to TgvAB and is also able to recognise 7-deazaguanine modified DNA. Furthermore, although GrwA, TgvB and GmrSD all share a similar domain architecture, except for the shared N-terminal DUF262 domain GrwB and TgvA are distinct from one another<sup><xref ref-type="bibr" rid="R25">25</xref></sup>.</p></sec><sec id="S7"><title><italic>Vc</italic>SduA is a Shedu system with a GHKL ATPase N-terminal domain</title><p id="P16"><italic>Vc</italic>SduA showed activity against all members of the T1-like <italic>Drexlerviridae</italic> family, with strong protection against Bas1 (&gt;10,000-fold), Bas03 and Bas08 (10-100-fold), while the remainder showed a reduced plaque diameter that in the case of Bas03 and Bas05 was drastic (<xref ref-type="fig" rid="F4">Fig. 4b</xref> and <xref ref-type="fig" rid="F14">Extended Data Fig. 9b</xref>). Sequence analysis and structural modelling showed that <italic>Vc</italic>SduA encodes an N-terminal GHKL (Gyrase, Hsp90, Histidine Kinase, MutL) ATPase domain (HATPase_c) containing the highly conserved motifs I-IV that define this ATPase superfamily<sup><xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R64">64</xref></sup>, followed by a C-terminal PD-(D/E)xK nuclease domain (DUF4263) that is also found in the Shedu defence system<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R65">65</xref>,<xref ref-type="bibr" rid="R66">66</xref></sup> (<xref ref-type="fig" rid="F4">Fig. 4f</xref> and <xref ref-type="fig" rid="F18">Extended Data Fig. 13a-c</xref>). Variants designed to disrupt either ATP hydrolysis <italic>Vc</italic>SduA[E27A] or nuclease activity <italic>Vc</italic>SduA[K557A] both abolished anti-phage activity despite being produced at similar levels to WT control (<xref ref-type="fig" rid="F4">Fig. 4g</xref> and <xref ref-type="fig" rid="F18">Extended Data Fig. 13d</xref>). Furthermore, growth kinetic experiments with phage-infected cultures revealed similarly robust protection at all tested MOIs (<xref ref-type="fig" rid="F4">Fig. 4h</xref>), consistent with <italic>Vc</italic>SduA targeting and restricting the phage directly while preserving the viability of the host cell.</p><p id="P17">Proteins with a similar domain organisation to <italic>Vc</italic>SduA were previously annotated as paraMORC3, and have recently been proposed to be part of the Shedu defence system family due to the presence of the signature Shedu domain DUF4263<sup><xref ref-type="bibr" rid="R64">64</xref>,<xref ref-type="bibr" rid="R65">65</xref></sup>. Indeed, Shedu has recently been re-classified as consisting of a shared nuclease domain with diverse N-terminal regulatory domains (Type I), including various enzymatic domains (Type I-D)<sup><xref ref-type="bibr" rid="R65">65</xref></sup>. Strikingly, modelling of <italic>Vc</italic>SduA as a dimer (<xref ref-type="fig" rid="F4">Fig. 4f</xref>), which are typical for GHKL ATPases, confidently predicted an entwined configuration with the GHKL ATPase domain sitting below a cavity formed by a clamp-like middle domain, which in other GHKL family members mediates binding to DNA and protein substrates<sup><xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R67">67</xref></sup>. We therefore hypothesise that the GHKL ATPase domain functions to control the activity of the C-terminal nuclease domain. Interestingly, modelling of <italic>Vc</italic>SduA as a tetramer was not well-supported (<xref ref-type="fig" rid="F18">Extended Data Fig. 13e</xref>). Furthermore, <italic>Vc</italic>SduA homologues were present in ~1.2% of genomes examined (<xref ref-type="fig" rid="F18">Extended Data Fig. 13f</xref> and <xref ref-type="supplementary-material" rid="SD8">Supplementary Table 5</xref>), though GrwAB and <italic>Vc</italic>SduA were rarely found together outside of <italic>V. cholerae</italic>, consistent with the demonstration above that they are independent systems. Overall, these data show that <italic>Vc</italic>SduA is a newly identified member of the Shedu family and the first validated member of the type I-D class.</p></sec><sec id="S8"><title><italic>Vc</italic>SduA protects <italic>V. cholerae</italic> against vibriophage X29</title><p id="P18">Next, to determine whether GrwAB and <italic>Vc</italic>SduA were functional in their native <italic>V. cholerae</italic> host, we first searched the NCBI virus database for vibriophages with modified genomes that might be targeted by GrwAB (see methods). However, no such phage targeting <italic>V. cholerae</italic> were identified (<xref ref-type="supplementary-material" rid="SD9">Supplementary Table 6</xref>). We therefore screened a collection of phages from the Félix d’Hérelle Reference Center for Bacterial Viruses, focussing on phage X29<sup><xref ref-type="bibr" rid="R68">68</xref></sup> as we determined that it requires the O-antigen for infection (<xref ref-type="fig" rid="F5">Fig. 5a</xref>). Importantly, Darracq <italic>et al</italic>., recently showed that the VSP-II encoded DdmABC defence system<sup><xref ref-type="bibr" rid="R24">24</xref></sup> protects <italic>V. cholerae</italic> against X29<sup><xref ref-type="bibr" rid="R69">69</xref></sup>. Indeed, deletion of <italic>ddmABC</italic> in the non-WASA 7PET strains tested here was sufficient to fully restore X29 plaque formation (<xref ref-type="fig" rid="F5">Fig. 5b</xref>). In contrast, deletion of <italic>ddmABC</italic> in the WASA-lineage strains A1552 and C6706 had no effect (<xref ref-type="fig" rid="F5">Fig. 5b</xref>), raising the possibility that the LAT-1 encoded defence systems of VSP-II<sup>WASA</sup> were active against X29. Consistent with this idea, while deletion of <italic>grwAB</italic> or <italic>VcSduA</italic> alone had no effect, deletion of either the entire LAT-1 region or <italic>VcSduA</italic> alone in a Δ<italic>ddmABC</italic> background restored X29 plaque formation to levels comparable to that of a complete VSP-II deletion (<xref ref-type="fig" rid="F5">Fig. 5c</xref>). Furthermore, ectopic expression of <italic>VcSduA</italic> complemented the Δ<italic>ddmABC</italic>Δ<italic>VcSduA</italic> deletion and conferred complete protection against X29 in non-WASA strains deleted for <italic>ddmABC</italic> (<xref ref-type="fig" rid="F5">Fig. 5d-e</xref>). Collectively, these data show that <italic>Vc</italic>SduA is active in its native host organism at native expression levels, and show that WASA lineage strains have two distinct mechanisms to defend against phage X29.</p></sec></sec><sec id="S9" sec-type="discussion"><title>Discussion</title><p id="P19">The main discovery of this work is that the two unique genetic signatures (WASA-1 and VSP-II<sup>WASA</sup>) of the WASA lineage encode three novel antiviral defence systems: WonAB, GrwAB, <italic>Vc</italic>SduA. Previously, these elements have primarily been used as a molecular signature to track the origins of these strains<sup>10,28-30,70</sup>, but their significance for the success of the lineage and the Latin American cholera epidemic has remained unknown. Here we demonstrate that combined these systems have broad activity against diverse bacteriophage families and target two-thirds of the isolates in the BASEL bacteriophage collection, including those with highly modified genomes. Importantly, we also show that in the native <italic>V. cholerae</italic> host, the WonAB system carried on the WASA-1 prophage renders strains resistant to ICP1 - the major predatory phage of pandemic <italic>V. cholerae</italic><sup><xref ref-type="bibr" rid="R8">8</xref></sup>. Given the ongoing arms race between <italic>V. cholerae</italic> and ICP1<sup><xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R14">14</xref></sup> and the suggested role of ICP1 predation in cholera epidemics<sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref></sup>, it is therefore reasonable to assume that this would have provided a significant selective advantage to the lineage. Nevertheless, since WonAB can also target other phages, then together with the systems carried on VSP-II<sup>WASA</sup>, this selective advantage may have been against phages other than ICP1. Indeed, the VSP-II<sup>WASA</sup>-encoded <italic>Vc</italic>SduA system protects WASA lineage strains against vibriophage X29, a myovirus that was originally isolated from a cholera patient in India in 1927<sup><xref ref-type="bibr" rid="R68">68</xref>,<xref ref-type="bibr" rid="R71">71</xref></sup>. Notably, spacers targeting X29 are abundant in the CRISPR-Cas systems present in classical 6<sup>th</sup> pandemic and non-7PET strains<sup><xref ref-type="bibr" rid="R72">72</xref>–<xref ref-type="bibr" rid="R74">74</xref></sup>, suggesting that X29 (or related phages) may be commonly encountered. Interestingly, since <italic>Vc</italic>SduA shares redundancy with DdmABC it could potentially serve to protect against X29 variants that have evolved DdmABC-resistance. However, given <italic>Vc</italic>SduA activity against <italic>Drexlerviridae</italic> in <italic>E. coli</italic> it is equally possible that it functions primarily against other non-DdmABC sensitive phages.</p><p id="P20">Prior to the start of the epidemic in 1991, Latin America had been free from pandemic cholera for almost 100 years<sup><xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R75">75</xref></sup>. However, following the introduction of the WASA lineage from West Africa in the late 1980’s, an explosive cholera epidemic spread rapidly throughout Latin America, with &gt;500,000 cases in Peru alone in 1991-92, and ongoing outbreaks continuing until 2001<sup>10,27,30,31,75,76</sup>. Given our findings we therefore propose that the combined activities of the defence systems encoded on WASA-1 and VSP-II<sup>WASA</sup> directly contributed to the success of the WASA lineage and envisage at least two possible scenarios by which this could have occurred. Firstly, the acquisition of these systems in Africa could have allowed the strains to resist local vibriophages, triggering the proliferation of the lineage that therefore facilitated the transfer to South America. Notably, cholera outbreaks were ongoing in Western and Central Africa just prior to the start of the Latin American epidemic, and intensified in the years afterwards<sup><xref ref-type="bibr" rid="R30">30</xref>,<xref ref-type="bibr" rid="R31">31</xref></sup>. Furthermore, strains containing WASA-1 and VSP-II<sup>WASA</sup> continued to circulate in Western/Central Africa up until the late 1990’s, including in the strains responsible for the 1987-1996 Angolan cholera epidemic<sup><xref ref-type="bibr" rid="R30">30</xref>,<xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R77">77</xref></sup>. Remarkably, we found WASA-1 (99.7% identity to A1552) in a recently sequenced non-7PET <italic>V. cholerae</italic> strain isolated in Switzerland in 2019 from a patient with a travel history to Morocco<sup><xref ref-type="bibr" rid="R78">78</xref></sup>, suggesting that WonAB-containing WASA-1 continues to circulate in Africa. Secondly, the defences provided by WASA-1 and VSP-II<sup>WASA</sup> could have played a more direct role in the transmission, for example by allowing the WASA lineage to overcome an entry barrier posed by phages associated with local non-pandemic <italic>V. cholerae</italic> strains endemic to South America that might have prevented previous introductions. In support of these proposals, the ability to defend against phage predation is thought to play a key role in the observed evolution of local <italic>V. cholerae</italic> lineages, which then go on to be successful before subsequently being replaced<sup><xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R14">14</xref></sup>. Indeed, the continuous antagonistic co-evolution of bacterial defences and phage encoded anti-defences drives the gain and loss of defence systems in natural <italic>vibrio</italic> populations, with such defences often encoded on mobile genetic elements (MGE) and accounting for a large proportion of the accessory genome<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R79">79</xref></sup>. Thus, while 7PET strains are typically considered to be clonal based on the phylogeny of the core genome, closely related-strains can harbour diverse MGEs encoding defence systems that vary over time in response to the dominant phages<sup><xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R14">14</xref></sup>. This, together with the results presented here, reinforces the need to consider the role of the accessory genomes in the success of novel lineages and therefore understanding their pandemic potential. Finally, while further work will be necessary to decipher the mechanistic details of the newly discovered defence systems, this work provides new insights into the evolution of one of the major epidemic lineages of the seventh cholera pandemic.</p></sec><sec id="S10" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S11"><title>Bacterial strains, plasmids and bacteriophages</title><p id="P21">The bacterial strains, plasmids, bacteriophages and defence systems used in this work are detailed in <xref ref-type="supplementary-material" rid="SD10">Supplementary Table 7</xref>. The primary <italic>V. cholerae</italic> strain used throughout this work, A1552, is an O1 El Tor (Inaba) strain isolated from a patient in 1992 following an outbreak of cholera linked to a commercial airline flight between Lima, Peru and Los Angeles, California, U.S.A<sup><xref ref-type="bibr" rid="R81">81</xref>–<xref ref-type="bibr" rid="R83">83</xref></sup>. The primary <italic>E. coli</italic> strain used throughout this work is the non-arabinose metabolising strain MG1655Δ<italic>araCBAD</italic><sup><xref ref-type="bibr" rid="R84">84</xref></sup>. <italic>E. coli</italic> strains S17-1λ<italic>pir</italic> and MFD<italic>pir</italic> were used for cloning and bacterial mating with plasmids containing the conditional R6K origin of replication<sup><xref ref-type="bibr" rid="R85">85</xref>,<xref ref-type="bibr" rid="R86">86</xref></sup>.</p></sec><sec id="S12"><title>Growth conditions</title><p id="P22">Bacteria were cultured either in Lysogeny broth (LB-Miller; 10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl; Carl Roth, Switzerland) with shaking at 180rpm or on LB + 1.5% agar plates, at 37°C. Transformation of <italic>V. cholerae</italic> was done on chitin powder (Alfa Aesar via Thermo Fisher, U.S.A) suspended in half-concentrated Instant Ocean medium (Aquarium Systems) and sterilised by autoclaving. Thiosulfate citrate bile salts sucrose (TCBS) agar plates were used for counter-selection against <italic>E. coli</italic> following bacterial mating (Sigma-Aldrich). SacB-based counter-selection for allelic exchange was done on NaCl-free media containing 10% sucrose. Counter-selection of <italic>pheS</italic>*-carrying strains (see below) was done on LB agar plates supplemented with 20 mM 4-chloro-phenylalanine (cPhe). Ampicillin (Amp; 100 μg/mL), chloramphenicol (Cm; 2.5 µg/mL), gentamicin (Gent; 25-50 μg/mL), kanamycin (Kan; 75 μg/mL), streptomycin (Strep; 100 μg/mL) and rifampicin (Rif; 100 μg/mL) were used for selection, as required. Growth of MFD<italic>pir</italic> was supported by the addition of 0.3 mM diaminopimelic acid (DAP; Sigma-Aldrich). Unless stated otherwise, genes under control of the <italic>P</italic><sub>BAD</sub>-promoter were induced by supplementing growth media with 0.2% L-arabinose.</p></sec><sec id="S13"><title>Strain construction</title><p id="P23">Genetic engineering of <italic>V. cholerae</italic> was done using natural competence for transformation to introduce deletions marked with antibiotic resistance genes<sup><xref ref-type="bibr" rid="R87">87</xref></sup>, which when necessary were removed using FLP recombination (TransFLP;<sup><xref ref-type="bibr" rid="R88">88</xref>,<xref ref-type="bibr" rid="R89">89</xref></sup>). Alternatively, antibiotic cassettes linked to the modified phenylalanyl-tRNA synthetase <italic>pheS</italic>* (<italic>pheS</italic>[A294G/T251A]) were removed by natural transformation using the Trans2 method<sup><xref ref-type="bibr" rid="R90">90</xref></sup>. Scar-less, marker-less modifications were introduced using allelic exchange with derivatives of the counter-selectable plasmid pGP704-Sac28<sup><xref ref-type="bibr" rid="R91">91</xref></sup>. A mini-Tn7 transposon carrying <italic>araC</italic> and the indicated gene(s) of interest under control of the <italic>P</italic><sub>BAD</sub>-promoter was integrated downstream of the <italic>glmS</italic> locus in <italic>V. cholerae</italic> and <italic>E. coli</italic> by introducing derivatives of pGP704-TnAraC via tri-parental mating, as previously described<sup><xref ref-type="bibr" rid="R92">92</xref></sup>. Plasmids were constructed using either standard restriction enzyme cloning or by inverse PCR, and were used exclusively as intermediates for strain construction. All strains and constructs were verified by PCR, and either Sanger sequencing or Oxford Nanopore Technologies (ONT)-based full plasmid sequencing (Microsynth AG, Switzerland).</p></sec><sec id="S14"><title><italic>V. cholerae</italic> bacteriophage methods</title><p id="P24">Vibriophages were propagated on <italic>V. cholerae</italic> strains E7946 or MAK757 (ICP1 and ICP3) and E7946Δ<italic>manCB</italic> (ICP2). Briefly, overnight cultures were back-diluted and grown in LB at 37°C, 180rpm to exponential phase (optical density at 600nm, OD<sub>600</sub> <italic>c.a</italic>. 0.5-0.6), infected with the relevant phage at a multiplicity of infection (MOI) of &lt;0.01. Following lysis of the culture, debris was removed by centrifugation (10min; 4,000 x <italic>g</italic>; RT), lysates passed through a 0.2µm filter, and stored at 4°C after the addition of chloroform to 1%. Phage titres were determined by plaque assays on strain E7946 using the small-drop plaque assay on double-layer plates, as described below. To quantify ICP and X29 phage infections, 100µL and 10µL, respectively, of overnight culture was added to molten top-agar (LB + 0.5% agar), poured on top of a bottom agar (LB + 1.5% agar), and allowed to solidify at RT. For complementation of <italic>wonAB</italic> and <italic>VcSduA</italic>, cultures were grown either for 2h + 0.2% arabinose or overnight with 0.02% arabinose, respectively, and the top agar was also supplemented with arabinose at the respective concentration. Phages were serially-diluted (10<sup>-1</sup>-10<sup>-8</sup>), 4µL of each dilution spotted onto plates, and allowed to dry under a laminar flow hood. Plates were imaged after overnight incubation at 37°C, and the plaque-forming units (PFU/mL) enumerated. The theoretical detection limit in this experiment was 2.5×10<sup>3</sup> PFU/mL. In cases where no discrete plaques were observed but a zone of non-specific lysis was apparent (<italic>e.g</italic>. ICP1 on strain A1552; <xref ref-type="fig" rid="F1">Fig. 1a</xref>), the last dilution exhibiting this phenotype was counted as 20 plaques. To determine whether these zones of non-specific lysis resulted from phage propagation or “lysis from without” (<italic>i.e</italic>. lysis at high phage concentration without viable phage production) re-streak tests were performed, as previously described<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. Material from the highest phage concentration spot on plaque assay plates was re-streaked onto freshly poured top agar plates containing the ICP1-sensitive strain A1552ΔWASA-1.</p></sec><sec id="S15"><title><italic>E. coli</italic> bacteriophage methods</title><p id="P25">The BASEL (BActeriophage SElection for your Laboratory) collection of <italic>E. coli</italic> bacteriophages was obtained from A. Harms, ETH Zürich<sup><xref ref-type="bibr" rid="R38">38</xref></sup>. Infections were quantified using the small-drop plaque assay described above, with the following modifications. Briefly, overnight cultures of <italic>E. coli</italic> MG1655Δ<italic>araCBAD</italic> were back-diluted 1:100 in 3mL LB + 5mM CaCl<sub>2</sub>, 20mM MgSO<sub>4</sub>, 0.2% arabinose and grown 2h at 37°C, 180rpm to reach exponential phase, before being diluted 1:40 in molten top agar, supplemented with 5mM CaCl<sub>2</sub>, 20mM MgSO<sub>4</sub> and 0.2% arabinose. Phages were serially-diluted (10<sup>-1</sup>-10<sup>-8</sup>), 5µL of each dilution spotted onto plates, and allowed to dry under a laminar flow hood. Plates were imaged after overnight incubation at 37°C, and the plaque-forming units (PFU/mL) enumerated. The theoretical detection limit in this experiment was 2×10<sup>3</sup> PFU/mL. Fold-protection was calculated as the ratio of PFU/mL on the strain of interest to that of the no system control strain <italic>E. coli</italic> MG1655Δ<italic>araCBAD</italic>-TnAraC.</p></sec><sec id="S16"><title>Quantification of infectious ICP1 phages</title><p id="P26">To monitor the production of infectious ICP1 phages, overnight cultures of the <italic>V. cholerae</italic> strains indicated in the text were back-diluted 1:100 in 2.5mL LB in 14mL test-tubes and grown at 37°C, 180rpm to exponential phase (OD<sub>600</sub> <italic>c.a</italic>. 0.5-0.6) before being infected with <italic>c.a</italic>. 10<sup>3</sup>-10<sup>4</sup> PFU/mL of ICP1-2006. Infected cultures were incubated at 37°C, 180rpm and sampled at 30min intervals for 2.5h. At each time-point, 300µL culture was mixed with 30µL of chloroform, vortexed vigorously for 10s and centrifuged (3min; 20,000 x <italic>g</italic>; RT). To determine the starting titre at time 0 samples were prepared from LB only controls. Chloroform-free supernatants were transferred to new tubes, serially diluted (10<sup>0</sup>-10<sup>-7</sup>) and PFU/mL enumerated by a plaque assay on plates seeded with the ICP1-sensitive <italic>V. cholerae</italic> strain E7946. The theoretical detection limit in this experiment was 2.5×10<sup>2</sup> PFU/mL.</p></sec><sec id="S17"><title>Bacteriophage infection kinetics</title><p id="P27">To monitor the kinetics of ICP1 infection, overnight cultures of the <italic>V. cholerae</italic> strains indicated in the text were back-diluted 1:100 in 2.5mL LB in 14mL test-tubes and grown at 37°C, 180rpm for 1h45min to exponential phase (OD<sub>600</sub> <italic>c.a</italic>. 0.5-0.6). 180µL aliquots of cultures diluted 1:5 in pre-warmed LB were added to the wells of a 96-well plate containing 20µL of ICP1-2006 at the indicated MOI (in technical triplicate). Bacterial growth (OD<sub>600</sub>) at 37°C with shaking was followed using a SpectraMax i3x (Molecular Devices) plate reader at 6-min intervals for a total of 49 cycles. The kinetics of Bas01, Bas24 and Bas37 infection in <italic>E. coli</italic> were monitored exactly as described above, except that <italic>E. coli</italic> strains were grown for 2h in LB + 5mM CaCl<sub>2</sub>, 20mM MgSO<sub>4</sub>, 0.2% arabinose and aliquots were diluted 1:10. <italic>E. coli</italic> phages used for plate reader experiments were propagated on MG1655Δ<italic>araCBAD</italic>, as described above.</p></sec><sec id="S18"><title>Microscopy</title><p id="P28">Imaging was conducted using Zeiss Axio Imager M2 and Zeiss Axio Observer Z1 epifluorescence microscopes, equipped with AxioCam MRm cameras and controlled by Zeiss Zen software (v.2.6 blue edition). Images were captured using a Plan-Apochromat 100x/1.4-NA Ph3 oil objective, and for fluorescence microscopy illumination with an HXP120 lamp. For snap-shot imaging, cells were immobilized on slides coated with 1.2% (wt/vol) agarose in PBS, covered with a No. 1 coverslip. For time-lapse microscopy, cells were immobilized on slides coated with 1.2% (wt/vol) agarose in either LB (ICP1 infection of <italic>V. cholerae</italic>) or LB + 5mM CaCl<sub>2</sub>, 20mM MgSO<sub>4</sub>, 0.2% arabinose (Bas24 infection of <italic>E. coli</italic>) and imaged automatically at the indicated time-points, within a temperature-controlled stage-top chamber (H301-K-Frame; OKO Lab, Italy) set to 37°C with an accompanying objective-heater. Images were prepared for publication using ImageJ (version 2.1.0/1.53h; <ext-link ext-link-type="uri" xlink:href="https://imagej.net/software/fiji/">imagej.net/software/fiji</ext-link>), and where needed, drift was corrected using the HyperStackRegPlus function of MicrobeJ<sup><xref ref-type="bibr" rid="R93">93</xref></sup>.</p></sec><sec id="S19"><title>Time-lapse and time-course microscopy of ICP1 infection</title><p id="P29">To image ICP1 infection in <italic>V. cholerae</italic>, overnight cultures of the strains indicated in the text were back-diluted 1:100 in 2.5mL LB in 14mL test-tubes and grown at 37°C, 180rpm for 1h45min to exponential phase (OD<sub>600</sub> <italic>c.a</italic>. 0.5-0.6). For time-lapse microscopy, an aliquot of the culture was then mixed with ICP1-2006 to achieve a MOI of 5, and immediately transferred to a slide and imaged, as described above. For time-course microscopy, 180µL aliquots of cultures were mixed with 20µL ICP1-2006 in 2mL microcentrifuge tubes to achieve a MOI of 5 and incubated flat at 37°C, 180rpm. At the indicated time-points, tubes were removed from the incubator and samples immediately transferred to a slide and imaged, as described above. To monitor cellular DNA content, strains were used encoding a C-terminal mNeonGreen fusion to the Histone-like DNA-binding protein HU (HU-mNeonGreen) separated by a GSGSGS linker, and expressed from the native <italic>hupA</italic> locus. To monitor ICP1 capsid assembly, infections were performed in strains with a chromosomally integrated transposon carrying a C-terminal mNeonGreen fusion to the ICP1 major capsid protein Gp122 (Gp122-mNeonGreen), separated by a GSGSGS linker, and expressed under the control of the arabinose-inducible <italic>P</italic><sub>BAD</sub>-promoter. The fusion was induced by the inclusion of 0.02% arabinose in the growth media.</p></sec><sec id="S20"><title>Time-lapse microscopy of Bas24 infection</title><p id="P30">To image Bas24 infection in <italic>E. coli</italic>, overnight cultures were back-diluted 1:100 in 3mL LB + 5mM CaCl<sub>2</sub>, 20mM MgSO<sub>4</sub>, 0.2% arabinose in 14mL test-tubes and grown at 37°C, 180rpm for 2h to mirror the conditions used for the BASEL screen above. An aliquot of the culture was then mixed with Bas24 to achieve a MOI of 10, and allowed to stand at RT for 2min before being transferred to a slide and imaged.</p></sec><sec id="S21"><title>Quantitative PCR (qPCR) of ICP1 genome replication</title><p id="P31">ICP1 genome replication was quantified by quantitative PCR (qPCR) using a protocol modified from<sup><xref ref-type="bibr" rid="R13">13</xref></sup>. Briefly, overnight cultures were back-diluted 1:100 in 2.5mL LB in 14mL test-tubes and grown at 37°C, 180rpm for 1h45min to exponential phase (OD<sub>600</sub> <italic>c.a</italic>. 0.5-0.6). ICP1-2006 was then added to a MOI of 0.1, tubes briefly vortexed to ensure proper mixing, and a 20µL sample immediately withdrawn (<italic>t</italic> = 0) and heat-inactivated at 95°C for 20min. Sampling was repeated following incubation at 37°C, 180rpm for 4, 8, 12, 16 and 20min post-infection. Samples were analysed using a LightCycler 96 Instrument (Roche) with SYBR Green I (Fast Start Essential DNA Green Master; Roche) to detect amplification products using the ICP1-specific primers qICP12006E_148-f (ACTTTGGTGCGTGAAGAAGG) and qICP12006E_148-r (ACTTGCTCACCTGAATGGTC). ICP1 genome copy number levels are presented relative to <italic>t</italic> = 0, and were analysed with LightCycler 96 software v.1.1.0.1320 (Roche) with the absolute quantification method using a standard curve of purified ICP1-2006 genomic DNA.</p></sec><sec id="S22"><title>WonB toxicity assay</title><p id="P32">Overnight cultures were back-diluted to OD<sub>600</sub> 0.05 in LB and grown 1h45min at 37°C, 180rpm to exponential phase (OD<sub>600</sub> <italic>c.a</italic>. 0.5-0.6), induced by the addition of 0.2% arabinose (<italic>t</italic> = 0), and incubation continued for 120min. The OD<sub>600</sub> of each culture was measured at <italic>t</italic> = 0, 15, 30, 60, and 120min. At each time point, samples were collected and processed to determine the (i) CFU/mL by serial-dilution and plating on LB agar, (ii) transcript levels via qRT-PCR and (iii) genomic DNA was prepared using a GenElute Bacterial Genomic DNA Kit (NA2110; Sigma-Aldrich) according to the manufacturer’s instructions. Samples to determine protein levels by Western blotting were collected at the time-points indicated in the text and processed as described below. To determine the stability of WonB protein levels over time, translation was inhibited by the addition of chloramphenicol to 200 µg/mL.</p></sec><sec id="S23"><title>Quantitative reverse transcription PCR (qRT-PCR) of <italic>wonAB</italic> transcript levels</title><p id="P33">2mL culture samples from the WonB toxicity assay (above) were harvested by centrifugation (3min; 20,000 x <italic>g</italic>; 4°C), cell pellets resuspended in Tri-Reagent (Sigma-Aldrich), snap-frozen in a dry ice-ethanol bath, and stored at -80°C. RNA extraction, cDNA synthesis, and qPCR was then performed exactly as previously described<sup><xref ref-type="bibr" rid="R94">94</xref></sup>, using a LightCycler 96 Instrument (Roche). Transcript levels are presented relative to mRNA levels of the reference gene <italic>gyrA</italic>, and were analysed with LightCycler 96 software v.1.1.0.1320 (Roche) using the standard curve method. Primers used to detect <italic>wonA and wonB</italic> were: qVC_01233-F (GTCCACAAGCAAACGGTAAG) and qVC_01233-R (TTCTCCCATGAATACCTCGG); qVC_01234-F (ACAACTGTCTCAAAGGATCC) and qVC_01234-R (GCTCAATATCCAGTCACATC).</p></sec><sec id="S24"><title>Western Blotting</title><p id="P34">Unless stated otherwise, overnight cultures were back-diluted 1:100 and grown at 37°C, 180rpm for 3h. Lysates were prepared by resuspending pelleted bacteria in 2x Laemmli buffer (Sigma-Aldrich), normalised to optical density (100 μL buffer per OD unit), and samples were then heated at 95°C, 15min. Proteins were resolved on Mini-PROTEAN TGX Stain-Free precast gels (10% or 12%, as required; Bio-Rad) and transferred onto PVDF membranes using a Trans-Blot Turbo Transfer System (Bio-Rad) according to the manufacturer’s instructions. Membranes were blocked in 2.5% skim milk in TBST (1x Tris-buffered saline with 0.1% Tween-20) with agitation at either RT for 1h or at 4°C overnight. Primary antibodies were added at a dilution of 1:500 in TBST and membranes incubated at RT for 1h. Membranes were then washed three times with TBST before being incubated at RT for 1h with anti-rabbit IgG conjugated to HRP (A9169, Sigma-Aldrich) diluted 1:20,000 in TBST. Membranes were washed as above and visualised by chemiluminescence using Lumi-Light<sup>PLUS</sup> Western Blotting Substrate (Roche). Primary antibodies against WonA (2210455), WonB (2210453) and <italic>Vc</italic>SduA (2310059) were custom-raised in rabbits against synthetic peptides (Eurogentec), and their specificity validated by comparing strains lacking the relevant proteins. Uniform sample loading was verified by the intensity of non-specific bands on the membranes or by detection of Sigma70 (1:10,000 diluted anti-Sigma70-HRP antibody from BioLegend, U.S.A).</p></sec><sec id="S25"><title>Identification of defence systems, protein domains, motifs and structural predictions</title><p id="P35">The repertoire of known defence systems present in <italic>V. cholerae</italic> strains was identified using DefenseFinder (v.1.2.4) and PADLOC (v.2.0.0) (accessed May 14<sup>th</sup> 2024), see <xref ref-type="supplementary-material" rid="SD4">Supplementary Table 1</xref> for details<sup><xref ref-type="bibr" rid="R95">95</xref>,<xref ref-type="bibr" rid="R96">96</xref></sup>. Conserved protein domains were initially identified by searching the PFAM and NCBI Conserved Domain Database with the MOTIF Search tool (<ext-link ext-link-type="uri" xlink:href="https://www.genome.jp/tools/motif/">genome.jp/tools/motif/</ext-link>; accessed July 22<sup>nd</sup> 2024), and was supplemented by remote homology searches using HHpred (PDB_mmCIF70_8_Mar, default database; accessed July 22<sup>nd</sup> 2024), and structural alignments performed with DALI using structural predictions generated by AlphaFold3<sup><xref ref-type="bibr" rid="R97">97</xref>–<xref ref-type="bibr" rid="R99">99</xref></sup>. The predicted template modelling (pTM) score, and where appropriate, the interface predicted template modelling (ipTM) score, are shown alongside each model<sup><xref ref-type="bibr" rid="R99">99</xref></sup>. For full confidence metrics for AlphaFold models, see <xref ref-type="supplementary-material" rid="SD3">Supplementary Fig. 1</xref>. Sequence logos showing the conservation of motifs in each system were generated using Weblogo 3 from multiple sequence alignments done using MAFFT<sup><xref ref-type="bibr" rid="R100">100</xref>,<xref ref-type="bibr" rid="R101">101</xref></sup>.</p></sec><sec id="S26"><title>Identification and distribution of WASA-1</title><p id="P36">A BLASTN search of the <italic>V. cholerae</italic> A1552 WASA-1 sequence (default parameters; evalue 1e-10) against 45,725 bacterial genomes (NCBI, Refseq database, complete and chromosome level genomes, downloaded on May 22<sup>nd</sup> 2024) revealed hits exclusively in the <italic>Vibrio</italic> genus. The BLASTN search was therefore repeated against a database consisting of 7,624 genomes, covering all available assemblies within the <italic>Vibrio</italic> genus (Refseq database, genomes from contig to complete level assemblies, downloaded on May 30<sup>th</sup> 2024). A second complementary BLASTN search was also performed with the additional max_hsps (high-scoring pair) parameter set to 1. Initial hits were then manually curated to identify complete WASA-1 assemblies, as shown in <xref ref-type="supplementary-material" rid="SD5">Supplementary Table 2</xref>. WASA-1 conservation was visualised using clinker (v.0.0.28, default parameters)<sup><xref ref-type="bibr" rid="R102">102</xref></sup>.</p></sec><sec id="S27"><title>Identification and distribution of defence systems</title><p id="P37">The presence of the WonAB, OLD-ABC ATPase + Novel REase, GrwAB and <italic>Vc</italic>SduA defence systems was determined against 45,725 bacterial genomes (NCBI, Refseq database, complete and chromosome level genomes, downloaded on May 22<sup>nd</sup> 2024) using MacSyFinder (v.2.1.1; default parameters)<sup><xref ref-type="bibr" rid="R103">103</xref></sup>. To build HMM profiles, a PSI-BLAST of each component was performed against the NCBI non-redundant protein sequence database (accessed in February 2023, and May 2024). The PSI-blast e-value threshold was set to 1e-10 and run for three iterations, except for <italic>Vc</italic>SduA for which only one iteration was performed due to NCBI computational constraints. Sequences were aligned using MAFFT (v.7.508; --maxiterate 1000 –localpair parameters for a higher accuracy alignment) and HMM profiles built using the hmmbuild function of the HMMER suite (v.3.3.2; default parameters)<sup><xref ref-type="bibr" rid="R101">101</xref>,<xref ref-type="bibr" rid="R104">104</xref></sup>. To evaluate the distribution of each system in the RefSeq database used, genera represented with more than 500 genomes were extracted, and the NCBI common tree tool used to create an order-level phylogenetic tree showing the most represented clades, with the presence/absence of each system mapped. For the full list of identified hits see <xref ref-type="supplementary-material" rid="SD6">Supplementary Tables 3</xref>-<xref ref-type="supplementary-material" rid="SD8">5</xref>.</p></sec><sec id="S28"><title>Isolation and characterisation of Bas24 escaper phages that overcome GrwAB</title><p id="P38">Candidate escaper phages of Bas24, which appeared as spontaneous large plaques in the lowest dilution of the small-drop plaque assay on strains producing GrwAB, were isolated and propagated using a protocol modified from<sup><xref ref-type="bibr" rid="R105">105</xref></sup>. Single plaques of each candidate were resuspended in 90µL phage buffer (50mM Tris-HCL pH 7.5, 100 mM MgCl<sub>2</sub>, 10mM NaCl), added to 1mL exponentially growing <italic>E. coli</italic> MG1655Δ<italic>araCBAD</italic> producing GrwAB in a 14mL test-tube and cultured at 37°C, 180rpm for 3h, at which point a further 2mL of exponentially growing culture was added and incubated for 3h, before phages were purified exactly as described above. As a control, a single plaque from the no system control plate was picked and propagated in the absence of GrwAB production. Genomic DNA was prepared using the Norgen Phage DNA Isolation Kit (Product #46850; Norgen, Canada) according to the manufacturer’s instructions. Whole genome sequencing was done using the Small, 200 Mbp Illumina short read service on the Illumina NextSeq2000 platform (SeqCoast Genomics, U.S.A). Genomes were assembled using Unicycler (v.0.5.0)<sup><xref ref-type="bibr" rid="R106">106</xref></sup>, using short reads only as input with the remaining parameters set to default, and assemblies rotated to match the Bas24 reference genome<sup><xref ref-type="bibr" rid="R107">107</xref></sup>. Genomes were aligned using MAFFT (v.7.508) and single nucleotide polymorphisms called using snp-sites (v.2.5.1)<sup><xref ref-type="bibr" rid="R101">101</xref>,<xref ref-type="bibr" rid="R108">108</xref></sup>.</p></sec><sec id="S29"><title>Search for DpdA-encoding vibriophages</title><p id="P39">To identify previously described vibriophages with modified genomes, phage sequences were downloaded from the NCBI virus database, with Vibrionaceae (taxid: 641) specified as the host. Using the resulting 1,700 nucleotide assemblies and the NCBI tool suite (v.2.14.1) to translate the sequences, a local database containing 117,034 protein sequences was generated (makeblastdb). This database was then searched for homologues of DpdA from phage Bas24 using Blastp (e-value 1e-10, rest of parameters to default). The resulting data are provided in <xref ref-type="supplementary-material" rid="SD9">Supplementary Table 6</xref>.</p></sec><sec id="S30"><title>Genome sequencing of Swiss WASA-1 strain N19-2759</title><p id="P40"><italic>V. cholerae</italic> strain N19-2759 is a non-O1/non-O139 non-toxigenic travel-associated clinical isolate isolated from a patient in Switzerland in 2019 (Illumina-based sequencing accession number GCA_032819675.1)<sup><xref ref-type="bibr" rid="R78">78</xref></sup>. To obtain an assembled complete genome of strain N19-2759, genomic DNA was prepared as previously described<sup><xref ref-type="bibr" rid="R109">109</xref></sup>, sequenced using ONT-based sequencing, and assembled using the software flye<sup><xref ref-type="bibr" rid="R110">110</xref></sup> [v. 2.9.3] (Microsynth, Switzerland).</p></sec></sec><sec sec-type="extended-data" id="S31"><title>Extended Data</title><fig id="F6" position="anchor"><label>Extended Data Fig. 1</label><caption><title>Control experiments showing role of WASA-1 prophage in ICP1 defence.</title><p id="P41">(<bold>a</bold>) Heat-map showing mean plaque-forming units (PFU/mL) of diverse ICP1-3 isolates determined by plaque assays on E7946 derivatives that lack either the O1 antigen receptor for ICP1 and ICP3 (E7946Δ<italic>manCB</italic>) or the OmpU receptor for ICP2 (E7946Δ<italic>ompU</italic>). (<bold>b</bold>) Plaque assay showing PFU/mL of various ICP1 isolates on A1552 in the presence and absence of WASA-1. (<bold>c</bold>) Re-streak tests evaluating the propagation of viable ICP1 phage progeny were conducted by taking material from the highest concentration spot of 10-fold serial dilution plaque assays done in the presence (A1552) and absence (ΔWASA-1) of WASA-1 (left) and re-streaking on fresh lawns of the susceptible ΔWASA-1 strain (right). (<bold>d</bold>) Replication assay showing change in PFU/mL over time following the infection of A1552 and E7946 cultures with <italic>c.a</italic>. 10<sup>3</sup>-10<sup>4</sup> PFU of ICP1-2006. (<bold>e</bold>) Heat-map showing mean plaque-forming units (PFU/mL) of diverse ICP1-3 isolates determined by plaque assays on A1552 derivatives that lack the indicated genomic islands, as compared to the pre-7<sup>th</sup> pandemic control strain MAK757. (<bold>f</bold>) Plaque assay showing the effects of introducing WASA-1, using versions with a kanamycin resistance cassette inserted at two different positions, into the non-WASA lineage strains E7946 and P27459 on ICP1-2006 PFU/mL, as compared to the equivalent A1552 control strains. Heat-maps and bar charts show the mean from 3 independent repeats. Error bars show s.d. and d.l. = detection limit.</p></caption><graphic xlink:href="EMS201156-f006"/></fig><fig id="F7" position="anchor"><label>Extended Data Fig. 2</label><caption><title>Conservation of the WASA-1 genome and identification of regions of interest.</title><p id="P42">(<bold>a</bold>) Schematic comparing the genome organisation of WASA-1 from <italic>V. cholerae</italic> strain A1552 with a representative set of examples of the WASA-1 detected by BLAST in diverse <italic>Vibrio spp</italic>. The schematic was built using the clinker pipeline and the connections between genomes are coloured according to protein identity (above the minimum default threshold of 30%). Genes with predicted functions in prophage biology are coloured according to function, as indicated. For details of WASA-1 identification and a full list of identified sequences, see methods and <xref ref-type="supplementary-material" rid="SD5">Supplementary Table 2</xref>. (<bold>b</bold>) Schematic of <italic>V. cholerae</italic> strain A1552 WASA-1 highlighting the genes that were highly expressed under standard growth conditions in RNA-seq results, and which were used to define the indicated regions of interest (ROI) 1-4. Note that ROI1 could only be deleted in the ΔROI4 background. The bar chart shows the effects of deleting each ROI on ICP1-2006 PFU/mL, as compared to WT and ΔWASA-1 control strains. Bars show the mean + s.d. from 3 independent repeats. d.l. = detection limit.</p></caption><graphic xlink:href="EMS201156-f007"/></fig><fig id="F8" position="anchor"><label>Extended Data Fig. 3</label><caption><title>Identification of conserved motifs and distribution of WonAB.</title><p id="P43">(<bold>a</bold>) Sequence logos showing conservation of the identified ABC-ATPase motifs in the 198 WonA hits detected using MacSyFinder v.2.1.1, as compared to the equivalent residue number in <italic>V. cholerae</italic> A1552 WonA. Amino acids in logos are coloured according to chemical properties: polar (G, S, T, Y, C), green; neutral (Q, N), purple; basic (K, R, H), blue; acidic (D, E), red; and hydrophobic (A, V, L, I, P, W, F, M), black. (<bold>b</bold>) Location of the conserved ABC-ATPase motifs shown in (<bold>a</bold>) at the dimer interface of the WonA dimer structural prediction. (<bold>c</bold>) Sequence logo showing the conservation of the identified PD-(D/E)xK nuclease motif in the 198 WonB hits detected using MacSyFinder v.2.1.1, compared to the equivalent residue number in <italic>V. cholerae</italic> A1552 WonB. (<bold>d</bold>) Location of the identified PD-(D/E)xK nuclease residues in the WonB structural prediction. (<bold>e</bold>) Western blot showing the protein levels of WonA and WonB, natively expressed in strain A1552 (WT) and in derivatives encoding the indicated site-directed variants. (<bold>f</bold>) Distribution of WonAB hits detected using MacSyFinder v.2.1.1. The tree shows the order-level phylogeny of genera in the RefSeq database with more than 500 genomes (see methods). For the full list of 198 WonAB hits see <xref ref-type="supplementary-material" rid="SD6">Supplementary Table 3</xref>.</p></caption><graphic xlink:href="EMS201156-f008"/></fig><fig id="F9" position="anchor"><label>Extended Data Fig. 4</label><caption><title>Summary of structural modelling of WonAB and related systems.</title><p id="P44">(<bold>a-e</bold>) Cartoon representations coloured by chain showing the AlphaFold3 predicted structures for WonAB, and the related OLD-ABC ATPase + Novel REase and PD-T4-4 systems. The ATPase components WonA, OLD-ABC ATPase and PD-T4-4_A were modelled as a monomer (<bold>a</bold>) and a dimer (<bold>b</bold>), and further modelled as a complex with either one (<bold>c</bold>) or two (<bold>d</bold>) copies of the nuclease components WonB, Novel REase and PD-T4-4_B. (<bold>e</bold>) Nuclease components modelled alone, highlighting the location of the predicted PD-(D/E)xK nuclease residues. The predicted template modelling (pTM) score, and where appropriate, the interface predicted template modelling (ipTM) score, are shown alongside each model. Protein sequences were obtained from NCBI: <italic>V. cholerae</italic> A1552 WonA (AWB73975.1) and WonB (AWB73976.1); <italic>Anaerovibrio lipolyticus</italic> DSM 3074 OLD-ABC ATPase (SHI83489.1) + Novel REase (SHI83462.1); <italic>E. coli</italic> MOD1-ECOR58 PD-T4-4_A (RCO57999.1) and PD-T4-4_B (RCO57988.1).</p></caption><graphic xlink:href="EMS201156-f009"/></fig><fig id="F10" position="anchor"><label>Extended Data Fig. 5</label><caption><title>Anti-phage activity of WonAB in <italic>E. coli</italic>.</title><p id="P45">Fold-protection against <italic>E. coli</italic> phages of the BASEL collection conferred by the production of WonAB in <italic>E. coli</italic> MG1655Δ<italic>araCBAD</italic>, as compared to a negative ‘no system’ control. The system was expressed from a chromosomally integrated transposon carrying the arabinose-inducible <italic>P</italic><sub>BAD</sub>-promoter, induced by the addition of 0.2% arabinose. Bar chart shows the mean of two independent experiments.</p></caption><graphic xlink:href="EMS201156-f010"/></fig><fig id="F11" position="anchor"><label>Extended Data Fig. 6</label><caption><title>Time-lapse microscopy of ICP1 infection.</title><p id="P46">(<bold>a</bold>) Control experiment showing time-lapse microscopy of exponentially growing cells of <italic>V. cholerae</italic> A1552 (WT) in the absence of phage infection. (<bold>b</bold>) Time-lapse microscopy comparing exponentially growing cells of <italic>V. cholerae</italic> WT and ΔWASA-1 strains after infection with ICP1-2006 at MOI 5. The panels depict the full-frame versions of the examples presented in <xref ref-type="fig" rid="F2">Fig. 2b</xref>. All images are representative of the results of three independent experiments. Scale bars = 20 µm.</p></caption><graphic xlink:href="EMS201156-f011"/></fig><fig id="F12" position="anchor"><label>Extended Data Fig. 7</label><caption><title>Imaging the fate of ICP1 infected cells.</title><p id="P47">(<bold>a</bold>) Time-course microscopy snapshots comparing the growth and cell morphology of <italic>V. cholerae</italic> A1552 cultures at 1, 2, 3, 4 and 5 hours after infection with ICP1-2006 at MOI 5, as compared to an uninfected control culture (+ LB). Note how the ICP1-infected culture initially contains only a few cells with normal morphology (white arrowheads), and that these cells increase in number as the culture rebounds, while the swollen ICP1-infected cells that are initially dominant persist for several hours before undergoing lysis (yellow arrowheads). (<bold>b</bold>) SytoxBlue-staining of <italic>V. cholerae</italic> A1552 cultures 1 hour after infection with ICP1-2006 at MOI 5, as compared to an uninfected control culture (+ LB). (<bold>c</bold>) Plaque assays testing the ability of ICP1-2006 and ICP3-2007 (which both require the O1 antigen receptor) to form plaques on cultures of A1552ΔWASA-1 that rebounded following ICP1-infection, as compared to a culture of the same strain that was grown without selection, and the set of indicated control strains. Note how neither ICP1-2006 nor ICP3-2007 are able to form plaques on the rebounded cultures, consistent with recovery of the culture being driven by the growth of spontaneous O1-antigen mutant cells. All images are representative of the results of three independent experiments. Scale bars = 20 µm.</p></caption><graphic xlink:href="EMS201156-f012"/></fig><fig id="F13" position="anchor"><label>Extended Data Fig. 8</label><caption><title>Control experiments showing details of toxicity during WonB overproduction.</title><p id="P48">(<bold>a</bold>) Toxicity assay evaluating the growth of 10-fold serial dilutions of cultures of <italic>V. cholerae</italic> strain A1552 derivatives with a chromosomally integrated transposon carrying the indicated genes under the control of the arabinose-inducible <italic>P</italic><sub>BAD</sub>-promoter, in the absence (LB) and presence of induction (+ 0.2% ara), as compared to a negative control strain. (<bold>b</bold>) Toxicity assay evaluating the growth of 10-fold serial dilutions of <italic>V. cholerae</italic> strain A1552 and the indicated derivatives encoding site-directed variants of WonA, compared to the indicated deletion control strains, in the absence (LB) and presence (+ 0.2% ara) of WonB overproduction. Note that the control strains are also shown separately in <xref ref-type="fig" rid="F3">Fig. 3a</xref>. (<bold>c</bold>) Western blots showing the protein levels of WonA and WonB in the strains used for the toxicity assay shown in (<bold>b</bold>). Samples were taken from exponentially growing cultures, 15 minutes after induction of <italic>P</italic><sub>BAD</sub>-<italic>wonB</italic>. (<bold>d</bold>) Time-course microscopy snapshots showing the effect of WonB overproduction on cell morphology and cellular DNA content, as monitored by a HupA-mNeonGreen fusion, compared to a negative control strain and a strain overproducing the inactive WonB[K71A] variant. Scale bar = 5 µm. The panels depict the full time-series for the examples presented in <xref ref-type="fig" rid="F3">Fig. 3d</xref>. (<bold>e</bold>-<bold>f</bold>) Agarose gels evaluating the integrity of genomic DNA extractions (<bold>e</bold>) and comparison of <italic>wonA</italic> and <italic>wonB</italic> transcript levels as determined by qRT-PCR (<bold>f</bold>), prepared from cultures over time upon WonB overproduction following induction in exponentially growing cells at time 0, as compared to a negative control strain and a strain overproducing the inactive WonB[K71A] variant. All data are representative of the results of three independent repats. Bar charts show the mean + s.d.</p></caption><graphic xlink:href="EMS201156-f013"/></fig><fig id="F14" position="anchor"><label>Extended Data Fig. 9</label><caption><title>Anti-phage activity of GrwAB and <italic>Vc</italic>SduA in <italic>E. coli</italic>.</title><p id="P49">(<bold>a</bold>) Fold-protection against <italic>E. coli</italic> phages of the BASEL collection conferred by the production of either GrwA, GrwB, <italic>Vc</italic>SduA, GrwAB or GrwAB-<italic>Vc</italic>SduA in <italic>E. coli</italic> MG1655Δ<italic>araCBAD</italic>, as compared to a negative ‘no system’ control. Genes were expressed from a chromosomally integrated transposon carrying the arabinose-inducible <italic>P</italic><sub>BAD</sub>-promoter, induced by the addition of 0.2% arabinose. Bar charts show the mean of two independent experiments. Bars with a black dot indicate phages exhibiting altered plaque morphology. (<bold>b</bold>) Representative examples of the altered plaque morphology phenotype observed for Bas03 and Bas05 in the presence of <italic>Vc</italic>SduA production.</p></caption><graphic xlink:href="EMS201156-f014"/></fig><fig id="F15" position="anchor"><label>Extended Data Fig. 10</label><caption><title>Identification of conserved motifs and distribution of GrwAB.</title><p id="P50">(<bold>a, d</bold>) Sequence logos showing conservation of the identified QR, DGQQR and FxxxN motifs in the DUF262 domains of the 471 GrwA (<bold>a</bold>) and 471 GrwB (<bold>d</bold>) hits detected using MacSyFinder v.2.1.1, as compared to the equivalent residue number in <italic>V. cholerae</italic> A1552 GrwA and GrwB. Amino acids in logos are coloured according to chemical properties: polar (G, S, T, Y, C), green; neutral (Q, N), purple; basic (K, R, H), blue; acidic (D, E), red; and hydrophobic (A, V, L, I, P, W, F, M), black. (<bold>b</bold>) Sequence logo showing the conservation of the identified His-Me (HNH) nuclease motif in the DUF1524 domain of the 471 GrwA hits detected using MacSyFinder v.2.1.1, as compared to the equivalent residue number in <italic>V. cholerae</italic> A1552 GrwA. (<bold>c</bold>) Location of the identified His-Me (HNH) nuclease motif residues in the GrwA structural prediction, highlighting the predicted ββα fold. (<bold>e</bold>) AlphaFold3 predicted structures of potential GrwAB complexes. Colour scheme as in (<bold>c</bold>). (<bold>f</bold>) Distribution of GrwAB hits detected using MacSyFinder v.2.1.1. The tree shows the order-level phylogeny of genera in the RefSeq database with more than 500 genomes (see methods). For the full list of 471 GrwAB hits see <xref ref-type="supplementary-material" rid="SD7">Supplementary Table 4</xref>.</p></caption><graphic xlink:href="EMS201156-f015"/></fig><fig id="F16" position="anchor"><label>Extended Data Fig. 11</label><caption><title>Bas24 escaper phages overcome GrwAB defence via mutations in the DNA modification pathway.</title><p id="P51">(<bold>a</bold>) Plaque assays evaluating the ability of 10-fold serial dilutions of Bas24 escaper phages to form plaques on <italic>E. coli</italic> MG1655Δ<italic>araCBAD</italic> in the absence (No system) and presence of GrwAB (+ GrwAB), as compared to the parental Bas24 stock and a control stock propagated in the absence of GrwAB. (<bold>b</bold>) SNP table summarising results of whole genome sequencing for each phage compared to the published Bas24 reference sequence. Light yellow (SNP), dark yellow (SNP targeting <italic>dpdA</italic> locus), HP (hypothetical protein). (<bold>c</bold>) Multiple-sequence alignment showing conservation of <italic>Queuovirinae</italic> (Bas19-25) homologues of the 7-deazaguanosine inserting enzyme DpdA, with the residues found to be substituted in the Bas24 escaper phages highlighted in red. (<bold>d</bold>) Locations of the substituted residues shown on predicted structure of Bas24 DpdA, generated using AlphaFold3, compared to the experimentally determined crystal structure of <italic>Salmonella enterica</italic> serovar Montevideo DpdA (PDB 7UI4) showing the active site highlighted in magenta.</p></caption><graphic xlink:href="EMS201156-f016"/></fig><fig id="F17" position="anchor"><label>Extended Data Fig. 12</label><caption><title>Time-lapse microscopy of Bas24 infection.</title><p id="P52">(<bold>a</bold>-<bold>b</bold>) Time-lapse microscopy of exponentially growing cells of <italic>E. coli</italic> MG1655Δ<italic>araCBAD</italic> in the absence (No system) and presence (+ GrwAB) of GrwAB production, in the absence (<bold>a</bold>) and presence (<bold>b</bold>) of infection with Bas24 at MOI 10. All images are representative of the results of three independent experiments. Scale bars = 20 µm.</p></caption><graphic xlink:href="EMS201156-f017"/></fig><fig id="F18" position="anchor"><label>Extended Data Fig. 13</label><caption><title>Identification of conserved motifs and distribution of <italic>Vc</italic>SduA.</title><p id="P53">(<bold>a</bold>-<bold>b</bold>) Sequence logos showing conservation of the identified GHKL ATPase motifs I-IV in the GHKL domain (<bold>a</bold>) and the identified PD-(D/E)xK nuclease motif in the DUF4263 domain (<bold>b</bold>) of the 543 <italic>Vc</italic>SduA hits detected using MacSyFinder v.2.1.1, as compared to the equivalent residue number in <italic>V. cholerae</italic> A1552 <italic>Vc</italic>SduA. Amino acids in logos are coloured according to chemical properties: polar (G, S, T, Y, C), green; neutral (Q, N), purple; basic (K, R, H), blue; acidic (D, E), red; and hydrophobic (A, V, L, I, P, W, F, M), black. (<bold>c</bold>) Location of the identified PD-(D/E)xK nuclease residues in the <italic>Vc</italic>SduA structural prediction. (<bold>d</bold>) Western blot showing the protein levels of <italic>Vc</italic>SduA, expressed in <italic>E. coli</italic> MG1655Δ<italic>araCBAD</italic> from a chromosomally integrated transposon carrying the arabinose-inducible <italic>P</italic><sub>BAD</sub>-promoter, induced by the addition of 0.2% arabinose, as compared to derivatives encoding the indicated site-directed variants. Sigma70 was used as a loading control. (<bold>e</bold>) AlphaFold3 predicted structure of potential <italic>Vc</italic>SduA tetramer. (<bold>f</bold>) Distribution of <italic>Vc</italic>SduA hits detected using MacSyFinder v.2.1.1. The tree shows the order-level phylogeny of genera in the RefSeq database with more than 500 genomes (see methods). For the full list of 543 <italic>Vc</italic>SduA hits see <xref ref-type="supplementary-material" rid="SD8">Supplementary Table 5</xref>.</p></caption><graphic xlink:href="EMS201156-f018"/></fig></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Movie 1</label><media xlink:href="EMS201156-supplement-Movie_1.avi" mimetype="video" mime-subtype="x-msvideo" id="d5aAcGbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Movie 2</label><media xlink:href="EMS201156-supplement-Movie_2.avi" mimetype="video" mime-subtype="x-msvideo" id="d5aAcGcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Supplementary Figure 1</label><media xlink:href="EMS201156-supplement-Supplementary_Figure_1.pdf" mimetype="application" mime-subtype="pdf" id="d5aAcGdB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Table 1</label><media xlink:href="EMS201156-supplement-Table_1.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d5aAcGeB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Table 2</label><media xlink:href="EMS201156-supplement-Table_2.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d5aAcGfB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD6"><label>Table 3</label><media xlink:href="EMS201156-supplement-Table_3.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d5aAcGgB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD7"><label>Table 4Table</label><media xlink:href="EMS201156-supplement-Table_4Table.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d5aAcGhB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD8"><label>Table 5</label><media xlink:href="EMS201156-supplement-Table_5.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d5aAcGiB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD9"><label>Table 6</label><media xlink:href="EMS201156-supplement-Table_6.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d5aAcGjB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD10"><label>Table 7</label><media xlink:href="EMS201156-supplement-Table_7.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d5aAcGkB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD11"><label>Supplementary information</label><media xlink:href="EMS201156-supplement-Supplementary_information.pdf" mimetype="application" mime-subtype="pdf" id="d5aAcGlB" position="anchor"/></supplementary-material></sec></body><back><ack id="S32"><title>Acknowledgments</title><p>We thank all the members of the Blokesch laboratory for constructive feedback throughout the project. We also gratefully acknowledge K. D. Seed (University of California, Berkeley), A. Camilli (Tufts University School of Medicine, Boston), W.-L. Ng (Tufts University School of Medicine, Boston) and A. Ali (University of Florida, Gainesville) for sharing ICP phages, and A. Harms (ETH, Zurich) for sharing the BASEL collection. We thank the Félix d’Hérelle Reference Center for Bacterial Viruses from the Université Laval (Québec, Canada) for providing phage X29 (HER66). Finally, we acknowledge Roger Stephan and Michael Biggel (University of Zurich) for sharing <italic>V. cholerae</italic> isolates from Switzerland and for valuable scientific discussions.</p><sec id="S33"><title>Funding</title><p>European Research Council Consolidator Grant 724630 (MB) Swiss National Research Foundation 310030_185022 (MB) HHMI International Scholarship 55008726 (MB) EPFL intramural funding (MB)</p></sec></ack><sec id="S34" sec-type="data-availability"><title>Data availability</title><p id="P54">The genome assemblies of <italic>V. cholerae</italic> strain N19-2759 have been deposited in the NCBI GenBank database under accession number <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/datasets/genome/GCF_046097525.1/">GCA_046097525.1</ext-link>. The raw reads are available from the Sequence Read Archive (SRA) under submission number <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/SRX26909066%5baccn%5d">SRX26909066</ext-link>. All other data are available in the main text or the supplementary materials.</p></sec><fn-group><fn fn-type="con" id="FN1"><p id="P55"><bold>Author contributions</bold></p><p id="P56">Conceptualization: DWA, MJ and MB Methodology: DWA, MJ, AL, and MB</p><p id="P57">Investigation: DWA, MJ, AL, SS, LR, LB and MB Visualization: DWA</p><p id="P58">Funding acquisition: MB Supervision: DWA and MB Writing – original draft: DWA</p><p id="P59">Writing – review &amp; editing: DWA, MJ and MB Writing – revision: DWA and MB</p></fn><fn fn-type="conflict" id="FN2"><p id="P60"><bold>Competing interests</bold></p><p id="P61">Authors declare that they have no competing interests.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georjon</surname><given-names>H</given-names></name><name><surname>Bernheim</surname><given-names>A</given-names></name></person-group><article-title>The highly diverse antiphage defence systems of bacteria</article-title><source>Nat Rev Microbiol</source><year>2023</year><volume>21</volume><fpage>686</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">37460672</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldor</surname><given-names>MK</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name></person-group><article-title>Lysogenic conversion by a filamentous phage encoding cholera toxin</article-title><source>Science</source><year>1996</year><volume>272</volume><fpage>1910</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8658163</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faruque</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><fpage>1702</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC547864</pub-id><pub-id pub-id-type="pmid">15653771</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0408992102</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faruque</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><fpage>6119</fpage><lpage>24</lpage><pub-id pub-id-type="pmcid">PMC1087956</pub-id><pub-id pub-id-type="pmid">15829587</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0502069102</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>MA</given-names></name><name><surname>Faruque</surname><given-names>SM</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name><name><surname>Levin</surname><given-names>BR</given-names></name></person-group><article-title>Modeling the role of bacteriophage in the control of cholera outbreaks</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>4652</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC1450226</pub-id><pub-id pub-id-type="pmid">16537404</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0600166103</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madi</surname><given-names>N</given-names></name><etal/></person-group><article-title>Phage predation, disease severity, and pathogen genetic diversity in cholera patients</article-title><source>Science</source><year>2024</year><volume>384</volume><elocation-id>eadj3166</elocation-id><pub-id pub-id-type="pmid">38669570</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seed</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Evidence of a dominant lineage of <italic>Vibrio cholerae</italic>-specific lytic bacteriophages shed by cholera patients over a 10-year period in Dhaka, Bangladesh</article-title><source>mBio</source><year>2011</year><volume>2</volume><fpage>e00334</fpage><lpage>10</lpage><pub-id pub-id-type="pmcid">PMC3037004</pub-id><pub-id pub-id-type="pmid">21304168</pub-id><pub-id pub-id-type="doi">10.1128/mBio.00334-10</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Bacteriophage ICP1: A Persistent Predator of <italic>Vibrio cholerae</italic></article-title><source>Annu Rev Virol</source><year>2021</year><volume>8</volume><fpage>285</fpage><lpage>304</lpage><pub-id pub-id-type="pmcid">PMC9040626</pub-id><pub-id pub-id-type="pmid">34314595</pub-id><pub-id pub-id-type="doi">10.1146/annurev-virology-091919-072020</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>M</given-names></name><name><surname>Cairns</surname><given-names>LS</given-names></name><name><surname>Camilli</surname><given-names>A</given-names></name></person-group><article-title>A cocktail of three virulent bacteriophages prevents <italic>Vibrio cholerae</italic> infection in animal models</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><elocation-id>14187</elocation-id><pub-id pub-id-type="pmcid">PMC5296635</pub-id><pub-id pub-id-type="pmid">28146150</pub-id><pub-id pub-id-type="doi">10.1038/ncomms14187</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutreja</surname><given-names>A</given-names></name><etal/></person-group><article-title>Evidence for several waves of global transmission in the seventh cholera pandemic</article-title><source>Nature</source><year>2011</year><volume>477</volume><fpage>462</fpage><lpage>5</lpage><pub-id pub-id-type="pmcid">PMC3736323</pub-id><pub-id pub-id-type="pmid">21866102</pub-id><pub-id pub-id-type="doi">10.1038/nature10392</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeGault</surname><given-names>KN</given-names></name><etal/></person-group><article-title>Temporal shifts in antibiotic resistance elements govern phage-pathogen conflicts</article-title><source>Science</source><year>2021</year><volume>373</volume><pub-id pub-id-type="pmcid">PMC9064180</pub-id><pub-id pub-id-type="pmid">34326207</pub-id><pub-id pub-id-type="doi">10.1126/science.abg2166</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seed</surname><given-names>KD</given-names></name><name><surname>Lazinski</surname><given-names>DW</given-names></name><name><surname>Calderwood</surname><given-names>SB</given-names></name><name><surname>Camilli</surname><given-names>A</given-names></name></person-group><article-title>A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity</article-title><source>Nature</source><year>2013</year><volume>494</volume><fpage>489</fpage><lpage>91</lpage><pub-id pub-id-type="pmcid">PMC3587790</pub-id><pub-id pub-id-type="pmid">23446421</pub-id><pub-id pub-id-type="doi">10.1038/nature11927</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Hara</surname><given-names>BJ</given-names></name><name><surname>Barth</surname><given-names>ZK</given-names></name><name><surname>McKitterick</surname><given-names>AC</given-names></name><name><surname>Seed</surname><given-names>KD</given-names></name></person-group><article-title>A highly specific phage defense system is a conserved feature of the <italic>Vibrio cholerae</italic> mobilome</article-title><source>PLoS Genet</source><year>2017</year><volume>13</volume><elocation-id>e1006838</elocation-id><pub-id pub-id-type="pmcid">PMC5481146</pub-id><pub-id pub-id-type="pmid">28594826</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006838</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angermeyer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Evolutionary Sweeps of Subviral Parasites and Their Phage Host Bring Unique Parasite Variants and Disappearance of a Phage CRISPR-Cas System</article-title><source>mBio</source><year>2022</year><volume>13</volume><fpage>e03088</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC8844924</pub-id><pub-id pub-id-type="pmid">35164562</pub-id><pub-id pub-id-type="doi">10.1128/mbio.03088-21</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seed</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Evolutionary consequences of intra-patient phage predation on microbial populations</article-title><source>Elife</source><year>2014</year><volume>3</volume><elocation-id>e03497</elocation-id><pub-id pub-id-type="pmcid">PMC4141277</pub-id><pub-id pub-id-type="pmid">25161196</pub-id><pub-id pub-id-type="doi">10.7554/eLife.03497</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckman</surname><given-names>DA</given-names></name><name><surname>Waters</surname><given-names>CM</given-names></name></person-group><article-title>Vibrio cholerae phage ICP3 requires O1 antigen for infection</article-title><source>Infect Immun</source><year>2023</year><volume>91</volume><elocation-id>e0002623</elocation-id><pub-id pub-id-type="pmcid">PMC10501212</pub-id><pub-id pub-id-type="pmid">37594274</pub-id><pub-id pub-id-type="doi">10.1128/iai.00026-23</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Emergence and Evolutionary Response of <italic>Vibrio cholerae</italic> to Novel Bacteriophage, Democratic Republic of the Congo</article-title><source>Emerg Infect Dis</source><year>2022</year><volume>28</volume><fpage>2482</fpage><lpage>90</lpage><pub-id pub-id-type="pmcid">PMC9707599</pub-id><pub-id pub-id-type="pmid">36417939</pub-id><pub-id pub-id-type="doi">10.3201/eid2812.220572</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>FA</given-names></name><etal/></person-group><article-title>Rapid evolutionary turnover of mobile genetic elements drives bacterial resistance to phages</article-title><source>Science</source><year>2021</year><volume>374</volume><fpage>488</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">34672730</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>BW</given-names></name><name><surname>Bogard</surname><given-names>RW</given-names></name><name><surname>Young</surname><given-names>TS</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name></person-group><article-title>Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for <italic>V. cholerae</italic> virulence</article-title><source>Cell</source><year>2012</year><volume>149</volume><fpage>358</fpage><lpage>70</lpage><pub-id pub-id-type="pmcid">PMC3620040</pub-id><pub-id pub-id-type="pmid">22500802</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2012.01.053</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doron</surname><given-names>S</given-names></name><etal/></person-group><article-title>Systematic discovery of antiphage defense systems in the microbial pangenome</article-title><source>Science</source><year>2018</year><volume>359</volume><pub-id pub-id-type="pmcid">PMC6387622</pub-id><pub-id pub-id-type="pmid">29371424</pub-id><pub-id pub-id-type="doi">10.1126/science.aar4120</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Severin</surname><given-names>GB</given-names></name><etal/></person-group><article-title>Direct activation of a phospholipase by cyclic GMP-AMP in El Tor <italic>Vibrio cholerae</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><fpage>E6048</fpage><lpage>E55</lpage><pub-id pub-id-type="pmcid">PMC6042076</pub-id><pub-id pub-id-type="pmid">29891656</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1801233115</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>D</given-names></name><etal/></person-group><article-title>Cyclic GMP-AMP signalling protects bacteria against viral infection</article-title><source>Nature</source><year>2019</year><volume>574</volume><fpage>691</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">31533127</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsueh</surname><given-names>BY</given-names></name><etal/></person-group><article-title>Phage defence by deaminase-mediated depletion of deoxynucleotides in bacteria</article-title><source>Nat Microbiol</source><year>2022</year><volume>7</volume><fpage>1210</fpage><lpage>20</lpage><pub-id pub-id-type="pmcid">PMC9830645</pub-id><pub-id pub-id-type="pmid">35817890</pub-id><pub-id pub-id-type="doi">10.1038/s41564-022-01162-4</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaskólska</surname><given-names>M</given-names></name><name><surname>Adams</surname><given-names>DW</given-names></name><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><article-title>Two defence systems eliminate plasmids from seventh pandemic <italic>Vibrio cholerae</italic></article-title><source>Nature</source><year>2022</year><volume>604</volume><fpage>323</fpage><lpage>29</lpage><pub-id pub-id-type="pmcid">PMC7613841</pub-id><pub-id pub-id-type="pmid">35388218</pub-id><pub-id pub-id-type="doi">10.1038/s41586-022-04546-y</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vizzarro</surname><given-names>G</given-names></name><name><surname>Lemopoulos</surname><given-names>A</given-names></name><name><surname>Adams</surname><given-names>DW</given-names></name><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><article-title><italic>Vibrio cholerae</italic> pathogenicity island 2 encodes two distinct types of restriction systems</article-title><source>J Bacteriol</source><year>2024</year><elocation-id>e0014524</elocation-id><pub-id pub-id-type="pmcid">PMC11411939</pub-id><pub-id pub-id-type="pmid">39133004</pub-id><pub-id pub-id-type="doi">10.1128/jb.00145-24</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>JB</given-names></name><name><surname>Waters</surname><given-names>CM</given-names></name></person-group><article-title>A <italic>Vibrio cholerae</italic> Type IV restriction system targets glucosylated 5-hydroxymethylcytosine to protect against phage infection</article-title><source>J Bacteriol</source><year>2024</year><elocation-id>e0014324</elocation-id><pub-id pub-id-type="pmcid">PMC11411926</pub-id><pub-id pub-id-type="pmid">39230524</pub-id><pub-id pub-id-type="doi">10.1128/jb.00143-24</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumate</surname><given-names>J</given-names></name><name><surname>Sepúlveda</surname><given-names>J</given-names></name><name><surname>Gutiérrez</surname><given-names>G</given-names></name></person-group><article-title>Cholera epidemiology in Latin America and perspectives for eradication</article-title><source>Bulletin de l’Institut Pasteur</source><year>1998</year><volume>96</volume><fpage>217</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/S0020-2452(99)80002-5</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusrin</surname><given-names>S</given-names></name><etal/></person-group><article-title>Peruvian <italic>Vibrio cholerae</italic> O1 El Tor strains possess a distinct region in the <italic>Vibrio</italic> seventh pandemic island-II that differentiates them from the prototype seventh pandemic El Tor strains</article-title><source>J Med Microbiol</source><year>2009</year><volume>58</volume><fpage>342</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">19208885</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garza</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Genome-wide study of the defective sucrose fermenter strain of <italic>Vibrio cholerae</italic> from the Latin American cholera epidemic</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><elocation-id>e37283</elocation-id><pub-id pub-id-type="pmcid">PMC3360680</pub-id><pub-id pub-id-type="pmid">22662140</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0037283</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domman</surname><given-names>D</given-names></name><etal/></person-group><article-title>Integrated view of <italic>Vibrio cholerae</italic> in the Americas</article-title><source>Science</source><year>2017</year><volume>358</volume><fpage>789</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">29123068</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weill</surname><given-names>FX</given-names></name><etal/></person-group><article-title>Genomic history of the seventh pandemic of cholera in Africa</article-title><source>Science</source><year>2017</year><volume>358</volume><fpage>785</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">29123067</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemos Rocha</surname><given-names>LF</given-names></name><etal/></person-group><article-title>The VarA-CsrA regulatory pathway influences cell shape in <italic>Vibrio cholerae</italic></article-title><source>PLoS Genet</source><year>2022</year><volume>18</volume><elocation-id>e1010143</elocation-id><pub-id pub-id-type="pmcid">PMC8989286</pub-id><pub-id pub-id-type="pmid">35344548</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1010143</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousset</surname><given-names>F</given-names></name><etal/></person-group><article-title>Phages and their satellites encode hotspots of antiviral systems</article-title><source>Cell Host Microbe</source><year>2022</year><volume>30</volume><fpage>740</fpage><lpage>53</lpage><elocation-id>e5</elocation-id><pub-id pub-id-type="pmcid">PMC9122126</pub-id><pub-id pub-id-type="pmid">35316646</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2022.02.018</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vassallo</surname><given-names>CN</given-names></name><name><surname>Doering</surname><given-names>CR</given-names></name><name><surname>Littlehale</surname><given-names>ML</given-names></name><name><surname>Teodoro</surname><given-names>GIC</given-names></name><name><surname>Laub</surname><given-names>MT</given-names></name></person-group><article-title>A functional selection reveals previously undetected anti-phage defence systems in the E. coli pangenome</article-title><source>Nat Microbiol</source><year>2022</year><volume>7</volume><fpage>1568</fpage><lpage>79</lpage><pub-id pub-id-type="pmcid">PMC9519451</pub-id><pub-id pub-id-type="pmid">36123438</pub-id><pub-id pub-id-type="doi">10.1038/s41564-022-01219-4</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>PH</given-names></name><name><surname>Maxwell</surname><given-names>KL</given-names></name></person-group><article-title>Prophages provide a rich source of antiphage defense systems</article-title><source>Curr Opin Microbiol</source><year>2023</year><volume>73</volume><elocation-id>102321</elocation-id><pub-id pub-id-type="pmid">37121062</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>A</given-names></name><name><surname>Burroughs</surname><given-names>AM</given-names></name><name><surname>Iyer</surname><given-names>LM</given-names></name><name><surname>Aravind</surname><given-names>L</given-names></name></person-group><article-title>Comprehensive classification of ABC ATPases and their functional radiation in nucleoprotein dynamics and biological conflict systems</article-title><source>Nucleic Acids Res</source><year>2020</year><volume>48</volume><fpage>10045</fpage><lpage>75</lpage><pub-id pub-id-type="pmcid">PMC7544218</pub-id><pub-id pub-id-type="pmid">32894288</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkaa726</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steczkiewicz</surname><given-names>K</given-names></name><name><surname>Muszewska</surname><given-names>A</given-names></name><name><surname>Knizewski</surname><given-names>L</given-names></name><name><surname>Rychlewski</surname><given-names>L</given-names></name><name><surname>Ginalski</surname><given-names>K</given-names></name></person-group><article-title>Sequence, structure and functional diversity of PD-(D/E)XK phosphodiesterase superfamily</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>7016</fpage><lpage>45</lpage><pub-id pub-id-type="pmcid">PMC3424549</pub-id><pub-id pub-id-type="pmid">22638584</pub-id><pub-id pub-id-type="doi">10.1093/nar/gks382</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maffei</surname><given-names>E</given-names></name><etal/></person-group><article-title>Systematic exploration of <italic>Escherichia coli</italic> phage-host interactions with the BASEL phage collection</article-title><source>PLoS Biol</source><year>2021</year><volume>19</volume><elocation-id>e3001424</elocation-id><pub-id pub-id-type="pmcid">PMC8594841</pub-id><pub-id pub-id-type="pmid">34784345</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3001424</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiltz</surname><given-names>CJ</given-names></name><name><surname>Adams</surname><given-names>MC</given-names></name><name><surname>Chappie</surname><given-names>JS</given-names></name></person-group><article-title>The full-length structure of <italic>Thermus scotoductus</italic> OLD defines the ATP hydrolysis properties and catalytic mechanism of Class 1 OLD family nucleases</article-title><source>Nucleic Acids Res</source><year>2020</year><volume>48</volume><fpage>2762</fpage><lpage>76</lpage><pub-id pub-id-type="pmcid">PMC7049728</pub-id><pub-id pub-id-type="pmid">32009148</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkaa059</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antine</surname><given-names>SP</given-names></name><etal/></person-group><article-title>Structural basis of Gabija anti-phage defence and viral immune evasion</article-title><source>Nature</source><year>2024</year><volume>625</volume><fpage>360</fpage><lpage>65</lpage><pub-id pub-id-type="pmcid">PMC10781630</pub-id><pub-id pub-id-type="pmid">37992757</pub-id><pub-id pub-id-type="doi">10.1038/s41586-023-06855-2</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burman</surname><given-names>N</given-names></name><etal/></person-group><article-title>A virally-encoded tRNA neutralizes the PARIS antiviral defence system</article-title><source>Nature</source><year>2024</year><pub-id pub-id-type="pmcid">PMC11464382</pub-id><pub-id pub-id-type="pmid">39111359</pub-id><pub-id pub-id-type="doi">10.1038/s41586-024-07874-3</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deep</surname><given-names>A</given-names></name><name><surname>Liang</surname><given-names>Q</given-names></name><name><surname>Enustun</surname><given-names>E</given-names></name><name><surname>Pogliano</surname><given-names>J</given-names></name><name><surname>Corbett</surname><given-names>KD</given-names></name></person-group><article-title>Architecture and activation mechanism of the bacterial PARIS defence system</article-title><source>Nature</source><year>2024</year><pub-id pub-id-type="pmcid">PMC11479591</pub-id><pub-id pub-id-type="pmid">39112702</pub-id><pub-id pub-id-type="doi">10.1038/s41586-024-07772-8</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defense</article-title><source>Nat Struct Mol Biol</source><year>2024</year><volume>31</volume><fpage>413</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">38177683</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dot</surname><given-names>EW</given-names></name><name><surname>Thomason</surname><given-names>LC</given-names></name><name><surname>Chappie</surname><given-names>JS</given-names></name></person-group><article-title>Everything OLD is new again: How structural, functional, and bioinformatic advances have redefined a neglected nuclease family</article-title><source>Mol Microbiol</source><year>2023</year><volume>120</volume><fpage>122</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">37254295</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>LJ</given-names></name><name><surname>Hughes</surname><given-names>TCD</given-names></name><name><surname>Fineran</surname><given-names>PC</given-names></name><name><surname>Jackson</surname><given-names>SA</given-names></name></person-group><article-title>New antiviral defences are genetically embedded within prokaryotic immune systems</article-title><source>bioRxiv</source><year>2024</year><elocation-id>2024.01.29.577857</elocation-id><pub-id pub-id-type="doi">10.1101/2024.01.29.577857</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousset</surname><given-names>F</given-names></name><name><surname>Sorek</surname><given-names>R</given-names></name></person-group><article-title>The evolutionary success of regulated cell death in bacterial immunity</article-title><source>Curr Opin Microbiol</source><year>2023</year><volume>74</volume><elocation-id>102312</elocation-id><pub-id pub-id-type="pmid">37030143</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seed</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Phase variable O antigen biosynthetic genes control expression of the major protective antigen and bacteriophage receptor in <italic>Vibrio cholerae</italic> O1</article-title><source>PLoS Pathog</source><year>2012</year><volume>8</volume><elocation-id>e1002917</elocation-id><pub-id pub-id-type="pmcid">PMC3441752</pub-id><pub-id pub-id-type="pmid">23028317</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002917</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barth</surname><given-names>ZK</given-names></name><name><surname>Netter</surname><given-names>Z</given-names></name><name><surname>Angermeyer</surname><given-names>A</given-names></name><name><surname>Bhardwaj</surname><given-names>P</given-names></name><name><surname>Seed</surname><given-names>KD</given-names></name></person-group><article-title>A Family of Viral Satellites Manipulates Invading Virus Gene Expression and Can Affect Cholera Toxin Mobilization</article-title><source>mSystems</source><year>2020</year><volume>5</volume><pub-id pub-id-type="pmcid">PMC7567579</pub-id><pub-id pub-id-type="pmid">33051375</pub-id><pub-id pub-id-type="doi">10.1128/mSystems.00358-20</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKitterick</surname><given-names>AC</given-names></name><name><surname>Hays</surname><given-names>SG</given-names></name><name><surname>Johura</surname><given-names>FT</given-names></name><name><surname>Alam</surname><given-names>M</given-names></name><name><surname>Seed</surname><given-names>KD</given-names></name></person-group><article-title>Viral Satellites Exploit Phage Proteins to Escape Degradation of the Bacterial Host Chromosome</article-title><source>Cell Host Microbe</source><year>2019</year><volume>26</volume><fpage>504</fpage><lpage>14</lpage><elocation-id>e4</elocation-id><pub-id pub-id-type="pmcid">PMC6910227</pub-id><pub-id pub-id-type="pmid">31600502</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2019.09.006</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurenas</surname><given-names>D</given-names></name><name><surname>Fraikin</surname><given-names>N</given-names></name><name><surname>Goormaghtigh</surname><given-names>F</given-names></name><name><surname>Van Melderen</surname><given-names>L</given-names></name></person-group><article-title>Biology and evolution of bacterial toxin-antitoxin systems</article-title><source>Nat Rev Microbiol</source><year>2022</year><volume>20</volume><fpage>335</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">34975154</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>KM</given-names></name><name><surname>Seed</surname><given-names>KD</given-names></name></person-group><article-title>Sporadic phage defense in epidemic <italic>Vibrio cholerae</italic> mediated by the toxin-antitoxin system DarTG is countered by a phage-encoded antitoxin mimic</article-title><source>mBio</source><year>2024</year><volume>15</volume><elocation-id>e0011124</elocation-id><pub-id pub-id-type="pmcid">PMC11481870</pub-id><pub-id pub-id-type="pmid">39287445</pub-id><pub-id pub-id-type="doi">10.1128/mbio.00111-24</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonejuie</surname><given-names>P</given-names></name><name><surname>Burkart</surname><given-names>M</given-names></name><name><surname>Pogliano</surname><given-names>K</given-names></name><name><surname>Pogliano</surname><given-names>J</given-names></name></person-group><article-title>Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial molecules</article-title><source>Proc Natl Acad Sci U S A</source><year>2013</year><volume>110</volume><fpage>16169</fpage><lpage>74</lpage><pub-id pub-id-type="pmcid">PMC3791758</pub-id><pub-id pub-id-type="pmid">24046367</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1311066110</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>SG</given-names></name><name><surname>Johnson</surname><given-names>BA</given-names></name><name><surname>Ledoux</surname><given-names>CM</given-names></name><name><surname>Dörr</surname><given-names>T</given-names></name></person-group><article-title><italic>Vibrio cholerae</italic>’s mysterious Seventh Pandemic island (VSP-II) encodes novel Zur-regulated zinc starvation genes involved in chemotaxis and cell congregation</article-title><source>PLoS Genet</source><year>2021</year><volume>17</volume><elocation-id>e1009624</elocation-id><pub-id pub-id-type="pmcid">PMC8248653</pub-id><pub-id pub-id-type="pmid">34153031</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1009624</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutinet</surname><given-names>G</given-names></name><etal/></person-group><article-title>7-Deazaguanine modifications protect phage DNA from host restriction systems</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><elocation-id>5442</elocation-id><pub-id pub-id-type="pmcid">PMC6884629</pub-id><pub-id pub-id-type="pmid">31784519</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-13384-y</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutinet</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>de Crécy-Lagard</surname><given-names>V</given-names></name><name><surname>Weigele</surname><given-names>PR</given-names></name></person-group><article-title>Hypermodified DNA in Viruses of <italic>E. coli</italic> and <italic>Salmonella</italic></article-title><source>EcoSal Plus</source><year>2021</year><volume>9</volume><elocation-id>eESP00282019</elocation-id><pub-id pub-id-type="pmcid">PMC11163837</pub-id><pub-id pub-id-type="pmid">34910575</pub-id><pub-id pub-id-type="doi">10.1128/ecosalplus.ESP-0028-2019</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machnicka</surname><given-names>MA</given-names></name><name><surname>Kaminska</surname><given-names>KH</given-names></name><name><surname>Dunin-Horkawicz</surname><given-names>S</given-names></name><name><surname>Bujnicki</surname><given-names>JM</given-names></name></person-group><article-title>Phylogenomics and sequence-structure-function relationships in the GmrSD family of Type IV restriction enzymes</article-title><source>BMC Bioinformatics</source><year>2015</year><volume>16</volume><fpage>336</fpage><pub-id pub-id-type="pmcid">PMC4619093</pub-id><pub-id pub-id-type="pmid">26493560</pub-id><pub-id pub-id-type="doi">10.1186/s12859-015-0773-z</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X</given-names></name><etal/></person-group><article-title>Expression and purification of a single-chain Type IV restriction enzyme Eco94GmrSD and determination of its substrate preference</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><elocation-id>9747</elocation-id><pub-id pub-id-type="pmcid">PMC4437046</pub-id><pub-id pub-id-type="pmid">25988532</pub-id><pub-id pub-id-type="doi">10.1038/srep09747</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picton</surname><given-names>DM</given-names></name><etal/></person-group><article-title>The phage defence island of a multidrug resistant plasmid uses both BREX and type IV restriction for complementary protection from viruses</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><fpage>11257</fpage><lpage>73</lpage><pub-id pub-id-type="pmcid">PMC8565348</pub-id><pub-id pub-id-type="pmid">34657954</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkab906</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>X</given-names></name><etal/></person-group><article-title>SspABCD-SspE is a phosphorothioation-sensing bacterial defence system with broad anti-phage activities</article-title><source>Nat Microbiol</source><year>2020</year><volume>5</volume><fpage>917</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">32251370</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H</given-names></name><etal/></person-group><article-title>Nicking mechanism underlying the DNA phosphorothioate-sensing antiphage defense by SspE</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><elocation-id>6773</elocation-id><pub-id pub-id-type="pmcid">PMC9646914</pub-id><pub-id pub-id-type="pmid">36351933</pub-id><pub-id pub-id-type="doi">10.1038/s41467-022-34505-0</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jablonska</surname><given-names>J</given-names></name><name><surname>Matelska</surname><given-names>D</given-names></name><name><surname>Steczkiewicz</surname><given-names>K</given-names></name><name><surname>Ginalski</surname><given-names>K</given-names></name></person-group><article-title>Systematic classification of the His-Me finger superfamily</article-title><source>Nucleic Acids Res</source><year>2017</year><volume>45</volume><fpage>11479</fpage><lpage>94</lpage><pub-id pub-id-type="pmcid">PMC5714182</pub-id><pub-id pub-id-type="pmid">29040665</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkx924</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gedara</surname><given-names>SH</given-names></name><etal/></person-group><article-title>7-Deazaguanines in DNA: functional and structural elucidation of a DNA modification system</article-title><source>Nucleic Acids Res</source><year>2023</year><volume>51</volume><fpage>3836</fpage><lpage>54</lpage><pub-id pub-id-type="pmcid">PMC10164549</pub-id><pub-id pub-id-type="pmid">36928176</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkad141</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>R</given-names></name><name><surname>Inouye</surname><given-names>M</given-names></name></person-group><article-title>GHKL, an emergent ATPase/kinase superfamily</article-title><source>Trends Biochem Sci</source><year>2000</year><volume>25</volume><fpage>24</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10637609</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>LM</given-names></name><name><surname>Abhiman</surname><given-names>S</given-names></name><name><surname>Aravind</surname><given-names>L</given-names></name></person-group><article-title>MutL homologs in restriction-modification systems and the origin of eukaryotic MORC ATPases</article-title><source>Biol Direct</source><year>2008</year><volume>3</volume><fpage>8</fpage><pub-id pub-id-type="pmcid">PMC2292703</pub-id><pub-id pub-id-type="pmid">18346280</pub-id><pub-id pub-id-type="doi">10.1186/1745-6150-3-8</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Bacterial Shedu immune nucleases share a common enzymatic core regulated by diverse sensor domains</article-title><source>Mol Cell</source><year>2025</year><pub-id pub-id-type="pmcid">PMC11805627</pub-id><pub-id pub-id-type="pmid">39742666</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2024.12.004</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loeff</surname><given-names>L</given-names></name><name><surname>Walter</surname><given-names>A</given-names></name><name><surname>Rosalen</surname><given-names>GT</given-names></name><name><surname>Jinek</surname><given-names>M</given-names></name></person-group><article-title>DNA end sensing and cleavage by the Shedu anti-phage defense system</article-title><source>Cell</source><year>2025</year><pub-id pub-id-type="pmid">39742808</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbett</surname><given-names>KD</given-names></name><name><surname>Berger</surname><given-names>JM</given-names></name></person-group><article-title>Structural dissection of ATP turnover in the prototypical GHL ATPase TopoVI</article-title><source>Structure</source><year>2005</year><volume>13</volume><fpage>873</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">15939019</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolle</surname><given-names>P</given-names></name><name><surname>Gallut</surname><given-names>J</given-names></name><name><surname>Ducrest</surname><given-names>P</given-names></name><name><surname>Quiniou</surname><given-names>J</given-names></name></person-group><article-title>Recherches en vue d’établir une lysotypie pour les vibrions cholériques et les vibrions d’El-Tor</article-title><source>Rev Hyg Med soc</source><year>1962</year><volume>10</volume><fpage>91</fpage><lpage>126</lpage></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darracq</surname><given-names>B</given-names></name><etal/></person-group><article-title>Sedentary chromosomal integrons as biobanks of bacterial anti-phage defence systems</article-title><source>bioRxiv</source><year>2024</year><elocation-id>2024.07.02.601686</elocation-id><pub-id pub-id-type="doi">10.1101/2024.07.02.601686</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morais</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Population and genetic study of <italic>Vibrio cholerae</italic> from the amazon environment confirms that the WASA-1 prophage is the main marker of the epidemic strain that circulated in the region</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><elocation-id>e81372</elocation-id><pub-id pub-id-type="pmcid">PMC3841125</pub-id><pub-id pub-id-type="pmid">24303045</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0081372</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhandare</surname><given-names>SG</given-names></name><etal/></person-group><article-title>Complete Genome Sequences of <italic>Vibrio cholerae</italic>-Specific Bacteriophages 24 and X29</article-title><source>Genome Announc</source><year>2017</year><volume>5</volume><pub-id pub-id-type="pmcid">PMC5690320</pub-id><pub-id pub-id-type="pmid">29146843</pub-id><pub-id pub-id-type="doi">10.1128/genomeA.01013-17</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Box</surname><given-names>AM</given-names></name><name><surname>McGuffie</surname><given-names>MJ</given-names></name><name><surname>O’Hara</surname><given-names>BJ</given-names></name><name><surname>Seed</surname><given-names>KD</given-names></name></person-group><article-title>Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in <italic>Vibrio cholerae</italic> and Its Application in Bacteriophage Genome Engineering</article-title><source>J Bacteriol</source><year>2016</year><volume>198</volume><fpage>578</fpage><lpage>90</lpage><pub-id pub-id-type="pmcid">PMC4719448</pub-id><pub-id pub-id-type="pmid">26598368</pub-id><pub-id pub-id-type="doi">10.1128/JB.00747-15</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>MR</given-names></name><etal/></person-group><article-title>CRISPR-Cas and Contact-Dependent Secretion Systems Present on Excisable Pathogenicity Islands with Conserved Recombination Modules</article-title><source>J Bacteriol</source><year>2017</year><volume>199</volume><pub-id pub-id-type="pmcid">PMC5405205</pub-id><pub-id pub-id-type="pmid">28264992</pub-id><pub-id pub-id-type="doi">10.1128/JB.00842-16</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>ND</given-names></name><name><surname>Regmi</surname><given-names>A</given-names></name><name><surname>Morreale</surname><given-names>DP</given-names></name><name><surname>Borowski</surname><given-names>JD</given-names></name><name><surname>Boyd</surname><given-names>EF</given-names></name></person-group><article-title>CRISPR-Cas systems are present predominantly on mobile genetic elements in <italic>Vibrio</italic> species</article-title><source>BMC Genomics</source><year>2019</year><volume>20</volume><fpage>105</fpage><pub-id pub-id-type="pmcid">PMC6360697</pub-id><pub-id pub-id-type="pmid">30717668</pub-id><pub-id pub-id-type="doi">10.1186/s12864-019-5439-1</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauxe</surname><given-names>RV</given-names></name><name><surname>Mintz</surname><given-names>ED</given-names></name><name><surname>Quick</surname><given-names>RE</given-names></name></person-group><article-title>Epidemic cholera in the new world: translating field epidemiology into new prevention strategies</article-title><source>Emerg Infect Dis</source><year>1995</year><volume>1</volume><fpage>141</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC2626892</pub-id><pub-id pub-id-type="pmid">8903186</pub-id><pub-id pub-id-type="doi">10.3201/eid0104.950408</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorman</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Genomics of the Argentinian cholera epidemic elucidate the contrasting dynamics of epidemic and endemic <italic>Vibrio cholerae</italic></article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><elocation-id>4918</elocation-id><pub-id pub-id-type="pmcid">PMC7530988</pub-id><pub-id pub-id-type="pmid">33004800</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-18647-7</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valia</surname><given-names>R</given-names></name><etal/></person-group><article-title><italic>Vibrio cholerae</italic> O1 epidemic variants in Angola: a retrospective study between 1992 and 2006</article-title><source>Front Microbiol</source><year>2013</year><volume>4</volume><fpage>354</fpage><pub-id pub-id-type="pmcid">PMC3842873</pub-id><pub-id pub-id-type="pmid">24348465</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2013.00354</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>N</given-names></name><name><surname>Stephan</surname><given-names>R</given-names></name><name><surname>Cernela</surname><given-names>N</given-names></name><name><surname>Horlbog</surname><given-names>JA</given-names></name><name><surname>Biggel</surname><given-names>M</given-names></name></person-group><article-title>Genomic characteristics of clinical non-toxigenic <italic>Vibrio cholerae</italic> isolates in Switzerland: a cross-sectional study</article-title><source>Swiss Med Wkly</source><year>2024</year><volume>154</volume><elocation-id>3437</elocation-id><pub-id pub-id-type="pmid">38579327</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piel</surname><given-names>D</given-names></name><etal/></person-group><article-title>Phage-host coevolution in natural populations</article-title><source>Nat Microbiol</source><year>2022</year><volume>7</volume><fpage>1075</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">35760840</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>ANW</given-names></name><name><surname>Yen</surname><given-names>M</given-names></name><name><surname>Seed</surname><given-names>KD</given-names></name><name><surname>Lazinski</surname><given-names>DW</given-names></name><name><surname>Camilli</surname><given-names>A</given-names></name></person-group><article-title>A Tail Fiber Protein and a Receptor-Binding Protein Mediate ICP2 Bacteriophage Interactions with <italic>Vibrio cholerae</italic> OmpU</article-title><source>J Bacteriol</source><year>2021</year><volume>203</volume><elocation-id>e0014121</elocation-id><pub-id pub-id-type="pmcid">PMC8316142</pub-id><pub-id pub-id-type="pmid">33875544</pub-id><pub-id pub-id-type="doi">10.1128/JB.00141-21</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberhart-Phillips</surname><given-names>J</given-names></name><etal/></person-group><article-title>An outbreak of cholera from food served on an international aircraft</article-title><source>Epidemiol Infect</source><year>1996</year><volume>116</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC2271246</pub-id><pub-id pub-id-type="pmid">8626007</pub-id><pub-id pub-id-type="doi">10.1017/s0950268800058891</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yildiz</surname><given-names>FH</given-names></name><name><surname>Schoolnik</surname><given-names>GK</given-names></name></person-group><article-title>Role of <italic>rpoS</italic> in stress survival and virulence of <italic>Vibrio cholerae</italic></article-title><source>J Bacteriol</source><year>1998</year><volume>180</volume><fpage>773</fpage><lpage>84</lpage><pub-id pub-id-type="pmcid">PMC106954</pub-id><pub-id pub-id-type="pmid">9473029</pub-id><pub-id pub-id-type="doi">10.1128/jb.180.4.773-784.1998</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthey</surname><given-names>N</given-names></name><name><surname>Drebes</surname><given-names>Dörr</given-names></name><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><article-title>Long-Read-Based Genome Sequences of Pandemic and Environmental <italic>Vibrio cholerae</italic> Strains</article-title><source>Microbiol Resour Announc</source><year>2018</year><volume>7</volume><pub-id pub-id-type="pmcid">PMC6298558</pub-id><pub-id pub-id-type="pmid">30574591</pub-id><pub-id pub-id-type="doi">10.1128/MRA.01574-18</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>SK</given-names></name><etal/></person-group><article-title>A universal biomolecular integral feedback controller for robust perfect adaptation</article-title><source>Nature</source><year>2019</year><volume>570</volume><fpage>533</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">31217585</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>R</given-names></name><name><surname>Priefer</surname><given-names>U</given-names></name><name><surname>Pühler</surname><given-names>A</given-names></name></person-group><article-title>A Broad Host Range Mobilization System for In Vivo Genetic Engineering: Transposon Mutagenesis in Gram Negative Bacteria</article-title><source>Bio/Technology</source><year>1983</year><volume>1</volume><fpage>784</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1038/nbt1183-784</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrières</surname><given-names>L</given-names></name><etal/></person-group><article-title>Silent mischief: bacteriophage Mu insertions contaminate products of <italic>Escherichia coli</italic> random mutagenesis performed using suicidal transposon delivery plasmids mobilized by broad-host-range RP4 conjugative machinery</article-title><source>J Bacteriol</source><year>2010</year><volume>192</volume><fpage>6418</fpage><lpage>27</lpage><pub-id pub-id-type="pmcid">PMC3008518</pub-id><pub-id pub-id-type="pmid">20935093</pub-id><pub-id pub-id-type="doi">10.1128/JB.00621-10</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marvig</surname><given-names>RL</given-names></name><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><article-title>Natural transformation of <italic>Vibrio cholerae</italic> as a tool--optimizing the procedure</article-title><source>BMC Microbiol</source><year>2010</year><volume>10</volume><fpage>155</fpage><pub-id pub-id-type="pmcid">PMC2890613</pub-id><pub-id pub-id-type="pmid">20509862</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-10-155</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Souza Silva</surname><given-names>O</given-names></name><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><article-title>Genetic manipulation of <italic>Vibrio cholerae</italic> by combining natural transformation with FLP recombination</article-title><source>Plasmid</source><year>2010</year><volume>64</volume><fpage>186</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">20709100</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><article-title>TransFLP-a method to genetically modify <italic>Vibrio cholerae</italic> based on natural transformation and FLP-recombination</article-title><source>J Vis Exp</source><year>2012</year><pub-id pub-id-type="pmcid">PMC3490321</pub-id><pub-id pub-id-type="pmid">23093249</pub-id><pub-id pub-id-type="doi">10.3791/3761</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Henst</surname><given-names>C</given-names></name><etal/></person-group><article-title>Molecular insights into <italic>Vibrio cholerae</italic>’s intra-amoebal host-pathogen interactions</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><elocation-id>3460</elocation-id><pub-id pub-id-type="pmcid">PMC6110790</pub-id><pub-id pub-id-type="pmid">30150745</pub-id><pub-id pub-id-type="doi">10.1038/s41467-018-05976-x</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meibom</surname><given-names>KL</given-names></name><etal/></person-group><article-title>The <italic>Vibrio cholerae</italic> chitin utilization program</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><fpage>2524</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC356983</pub-id><pub-id pub-id-type="pmid">14983042</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0308707101</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Lies</surname><given-names>DP</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Roberts</surname><given-names>GP</given-names></name></person-group><article-title>An improved Tn7-based system for the single-copy insertion of cloned genes into chromosomes of gram-negative bacteria</article-title><source>Gene</source><year>1991</year><volume>109</volume><fpage>167</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1661697</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducret</surname><given-names>A</given-names></name><name><surname>Quardokus</surname><given-names>EM</given-names></name><name><surname>Brun</surname><given-names>YV</given-names></name></person-group><article-title>MicrobeJ, a tool for high throughput bacterial cell detection and quantitative analysis</article-title><source>Nat Microbiol</source><year>2016</year><volume>1</volume><elocation-id>16077</elocation-id><pub-id pub-id-type="pmcid">PMC5010025</pub-id><pub-id pub-id-type="pmid">27572972</pub-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.77</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Scrudato</surname><given-names>M</given-names></name><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><article-title>The regulatory network of natural competence and transformation of <italic>Vibrio cholerae</italic></article-title><source>PLoS Genet</source><year>2012</year><volume>8</volume><elocation-id>e1002778</elocation-id><pub-id pub-id-type="pmcid">PMC3380833</pub-id><pub-id pub-id-type="pmid">22737089</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002778</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesson</surname><given-names>F</given-names></name><etal/></person-group><article-title>Systematic and quantitative view of the antiviral arsenal of prokaryotes</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><elocation-id>2561</elocation-id><pub-id pub-id-type="pmcid">PMC9090908</pub-id><pub-id pub-id-type="pmid">35538097</pub-id><pub-id pub-id-type="doi">10.1038/s41467-022-30269-9</pub-id></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>PADLOC: a web server for the identification of antiviral defence systems in microbial genomes</article-title><source>Nucleic Acids Res</source><year>2022</year><volume>50</volume><fpage>W541</fpage><lpage>W50</lpage><pub-id pub-id-type="pmcid">PMC9252829</pub-id><pub-id pub-id-type="pmid">35639517</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkac400</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>L</given-names></name><etal/></person-group><article-title>A Completely Reimplemented MPI Bioinformatics Toolkit with a New HHpred Server at its Core</article-title><source>J Mol Biol</source><year>2018</year><volume>430</volume><fpage>2237</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">29258817</pub-id></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holm</surname><given-names>L</given-names></name><name><surname>Laiho</surname><given-names>A</given-names></name><name><surname>Törönen</surname><given-names>P</given-names></name><name><surname>Salgado</surname><given-names>M</given-names></name></person-group><article-title>DALI shines a light on remote homologs: One hundred discoveries</article-title><source>Protein Sci</source><year>2023</year><volume>32</volume><elocation-id>e4519</elocation-id><pub-id pub-id-type="pmcid">PMC9793968</pub-id><pub-id pub-id-type="pmid">36419248</pub-id><pub-id pub-id-type="doi">10.1002/pro.4519</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Accurate structure prediction of biomolecular interactions with AlphaFold 3</article-title><source>Nature</source><year>2024</year><volume>630</volume><fpage>493</fpage><lpage>500</lpage><pub-id pub-id-type="pmcid">PMC11168924</pub-id><pub-id pub-id-type="pmid">38718835</pub-id><pub-id pub-id-type="doi">10.1038/s41586-024-07487-w</pub-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crooks</surname><given-names>GE</given-names></name><name><surname>Hon</surname><given-names>G</given-names></name><name><surname>Chandonia</surname><given-names>JM</given-names></name><name><surname>Brenner</surname><given-names>SE</given-names></name></person-group><article-title>WebLogo: a sequence logo generator</article-title><source>Genome Res</source><year>2004</year><volume>14</volume><fpage>1188</fpage><lpage>90</lpage><pub-id pub-id-type="pmcid">PMC419797</pub-id><pub-id pub-id-type="pmid">15173120</pub-id><pub-id pub-id-type="doi">10.1101/gr.849004</pub-id></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname><given-names>K</given-names></name><name><surname>Standley</surname><given-names>DM</given-names></name></person-group><article-title>MAFFT multiple sequence alignment software version 7: improvements in performance and usability</article-title><source>Mol Biol Evol</source><year>2013</year><volume>30</volume><fpage>772</fpage><lpage>80</lpage><pub-id pub-id-type="pmcid">PMC3603318</pub-id><pub-id pub-id-type="pmid">23329690</pub-id><pub-id pub-id-type="doi">10.1093/molbev/mst010</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilchrist</surname><given-names>CLM</given-names></name><name><surname>Chooi</surname><given-names>YH</given-names></name></person-group><article-title>clinker &amp; clustermap.js: automatic generation of gene cluster comparison figures</article-title><source>Bioinformatics</source><year>2021</year><volume>37</volume><fpage>2473</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">33459763</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abby</surname><given-names>SS</given-names></name><name><surname>Néron</surname><given-names>B</given-names></name><name><surname>Ménager</surname><given-names>H</given-names></name><name><surname>Touchon</surname><given-names>M</given-names></name><name><surname>Rocha</surname><given-names>EP</given-names></name></person-group><article-title>MacSyFinder: a program to mine genomes for molecular systems with an application to CRISPR-Cas systems</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><elocation-id>e110726</elocation-id><pub-id pub-id-type="pmcid">PMC4201578</pub-id><pub-id pub-id-type="pmid">25330359</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0110726</pub-id></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eddy</surname><given-names>SR</given-names></name></person-group><article-title>Accelerated Profile HMM Searches</article-title><source>PLoS Comput Biol</source><year>2011</year><volume>7</volume><elocation-id>e1002195</elocation-id><pub-id pub-id-type="pmcid">PMC3197634</pub-id><pub-id pub-id-type="pmid">22039361</pub-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002195</pub-id></element-citation></ref><ref id="R105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stokar-Avihail</surname><given-names>A</given-names></name><etal/></person-group><article-title>Discovery of phage determinants that confer sensitivity to bacterial immune systems</article-title><source>Cell</source><year>2023</year><volume>186</volume><fpage>1863</fpage><lpage>76</lpage><elocation-id>e16</elocation-id><pub-id pub-id-type="pmid">37030292</pub-id></element-citation></ref><ref id="R106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wick</surname><given-names>RR</given-names></name><name><surname>Judd</surname><given-names>LM</given-names></name><name><surname>Gorrie</surname><given-names>CL</given-names></name><name><surname>Holt</surname><given-names>KE</given-names></name></person-group><article-title>Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads</article-title><source>PLoS Comput Biol</source><year>2017</year><volume>13</volume><elocation-id>e1005595</elocation-id><pub-id pub-id-type="pmcid">PMC5481147</pub-id><pub-id pub-id-type="pmid">28594827</pub-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005595</pub-id></element-citation></ref><ref id="R107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durbin</surname><given-names>R</given-names></name><name><surname>De Sanctis</surname><given-names>B</given-names></name><name><surname>Blumer</surname><given-names>M</given-names></name></person-group><article-title>Rotate: A command-line program to rotate circular DNA sequences to start at a given position or string</article-title><source>Wellcome Open Res</source><year>2023</year><volume>8</volume><fpage>401</fpage><pub-id pub-id-type="pmcid">PMC11056001</pub-id><pub-id pub-id-type="pmid">38680652</pub-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.19568.1</pub-id></element-citation></ref><ref id="R108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments</article-title><source>Microb Genom</source><year>2016</year><volume>2</volume><elocation-id>e000056</elocation-id><pub-id pub-id-type="pmcid">PMC5320690</pub-id><pub-id pub-id-type="pmid">28348851</pub-id><pub-id pub-id-type="doi">10.1099/mgen.0.000056</pub-id></element-citation></ref><ref id="R109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stutzmann</surname><given-names>S</given-names></name><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><article-title>Comparison of chitin-induced natural transformation in pandemic <italic>Vibrio cholerae</italic> O1 El Tor strains</article-title><source>Environ Microbiol</source><year>2020</year><volume>22</volume><fpage>4149</fpage><lpage>66</lpage><pub-id pub-id-type="pmcid">PMC7693049</pub-id><pub-id pub-id-type="pmid">32860313</pub-id><pub-id pub-id-type="doi">10.1111/1462-2920.15214</pub-id></element-citation></ref><ref id="R110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolmogorov</surname><given-names>M</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Pevzner</surname><given-names>PA</given-names></name></person-group><article-title>Assembly of long, error-prone reads using repeat graphs</article-title><source>Nat Biotechnol</source><year>2019</year><volume>37</volume><fpage>540</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">30936562</pub-id></element-citation></ref><ref id="R111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>New phage typing scheme for <italic>Vibrio cholerae</italic> O1 biotype El Tor strains</article-title><source>J Clin Microbiol</source><year>1993</year><volume>31</volume><fpage>1579</fpage><lpage>85</lpage><pub-id pub-id-type="pmcid">PMC265581</pub-id><pub-id pub-id-type="pmid">8315000</pub-id><pub-id pub-id-type="doi">10.1128/jcm.31.6.1579-1585.1993</pub-id></element-citation></ref><ref id="R112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drebes</surname><given-names>Dörr</given-names></name><name><surname>Lemopoulos</surname><given-names>A</given-names></name><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><article-title>Exploring Mobile Genetic Elements in <italic>Vibrio cholerae</italic></article-title><source>bioRxiv</source><year>2024</year><elocation-id>2024.07.25.605194</elocation-id><pub-id pub-id-type="doi">10.1101/2024.07.25.605194</pub-id></element-citation></ref><ref id="R113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidelberg</surname><given-names>JF</given-names></name><etal/></person-group><article-title>DNA sequence of both chromosomes of the cholera pathogen <italic>Vibrio cholerae</italic></article-title><source>Nature</source><year>2000</year><volume>406</volume><fpage>477</fpage><lpage>83</lpage><pub-id pub-id-type="pmcid">PMC8288016</pub-id><pub-id pub-id-type="pmid">10952301</pub-id><pub-id pub-id-type="doi">10.1038/35020000</pub-id></element-citation></ref><ref id="R114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>GD</given-names></name><name><surname>Woods</surname><given-names>A</given-names></name><name><surname>Chiang</surname><given-names>SL</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name></person-group><article-title>CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><fpage>3750</fpage><lpage>4</lpage><pub-id pub-id-type="pmcid">PMC46379</pub-id><pub-id pub-id-type="pmid">8475125</pub-id><pub-id pub-id-type="doi">10.1073/pnas.90.8.3750</pub-id></element-citation></ref><ref id="R115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>VL</given-names></name><name><surname>DiRita</surname><given-names>VJ</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name></person-group><article-title>Identification of <italic>toxS</italic>, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter</article-title><source>J Bacteriol</source><year>1989</year><volume>171</volume><fpage>1288</fpage><lpage>93</lpage><pub-id pub-id-type="pmcid">PMC209743</pub-id><pub-id pub-id-type="pmid">2646275</pub-id><pub-id pub-id-type="doi">10.1128/jb.171.3.1288-1293.1989</pub-id></element-citation></ref><ref id="R116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wachsmuth</surname><given-names>IK</given-names></name><etal/></person-group><article-title>The molecular epidemiology of cholera in Latin America</article-title><source>J Infect Dis</source><year>1993</year><volume>167</volume><fpage>621</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7680060</pub-id></element-citation></ref><ref id="R117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blokesch</surname><given-names>M</given-names></name><name><surname>Schoolnik</surname><given-names>GK</given-names></name></person-group><article-title>Serogroup conversion of <italic>Vibrio cholerae</italic> in aquatic reservoirs</article-title><source>PLoS Pathog</source><year>2007</year><volume>3</volume><fpage>e81</fpage><pub-id pub-id-type="pmcid">PMC1891326</pub-id><pub-id pub-id-type="pmid">17559304</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0030081</pub-id></element-citation></ref><ref id="R118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzger</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Independent Regulation of Type VI Secretion in <italic>Vibrio cholerae</italic> by TfoX and TfoY</article-title><source>Cell Rep</source><year>2016</year><volume>15</volume><fpage>951</fpage><lpage>58</lpage><pub-id pub-id-type="pmcid">PMC4858559</pub-id><pub-id pub-id-type="pmid">27117415</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2016.03.092</pub-id></element-citation></ref><ref id="R119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>DW</given-names></name><name><surname>Stutzmann</surname><given-names>S</given-names></name><name><surname>Stoudmann</surname><given-names>C</given-names></name><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><article-title>DNA-uptake pili of <italic>Vibrio cholerae</italic> are required for chitin colonization and capable of kin recognition via sequence-specific self-interaction</article-title><source>Nat Microbiol</source><year>2019</year><volume>4</volume><fpage>1545</fpage><lpage>57</lpage><pub-id pub-id-type="pmcid">PMC6708440</pub-id><pub-id pub-id-type="pmid">31182799</pub-id><pub-id pub-id-type="doi">10.1038/s41564-019-0479-5</pub-id></element-citation></ref><ref id="R120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angermeyer</surname><given-names>A</given-names></name><name><surname>Das</surname><given-names>MM</given-names></name><name><surname>Singh</surname><given-names>DV</given-names></name><name><surname>Seed</surname><given-names>KD</given-names></name></person-group><article-title>Analysis of 19 Highly Conserved <italic>Vibrio cholerae</italic> Bacteriophages Isolated from Environmental and Patient Sources Over a Twelve-Year Period</article-title><source>Viruses</source><year>2018</year><volume>10</volume><pub-id pub-id-type="pmcid">PMC6024749</pub-id><pub-id pub-id-type="pmid">29857590</pub-id><pub-id pub-id-type="doi">10.3390/v10060299</pub-id></element-citation></ref><ref id="R121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Hara</surname><given-names>BJ</given-names></name><name><surname>Alam</surname><given-names>M</given-names></name><name><surname>Ng</surname><given-names>WL</given-names></name></person-group><article-title>The <italic>Vibrio cholerae</italic> Seventh Pandemic Islands act in tandem to defend against a circulating phage</article-title><source>PLoS Genet</source><year>2022</year><volume>18</volume><elocation-id>e1010250</elocation-id><pub-id pub-id-type="pmcid">PMC9455884</pub-id><pub-id pub-id-type="pmid">36026491</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1010250</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><title>WonAB carried on WASA-1 prophage renders WASA lineage ICP1 resistant.</title><p>(<bold>a</bold>) Heat-map showing mean plaque-forming units (PFU/mL) of diverse ICP1-3 isolates determined by plaque assays on wave 1 <italic>V. cholerae</italic> strains, as compared to a pre-7<sup>th</sup> pandemic control (MAK757), shown alongside 10-fold serial dilution plaque assays of ICP1-2006. Data represent the results of three independent repeats. Strain P27459 encodes a naturally occurring resistant variant of the ICP2 receptor OmpU<sup><xref ref-type="bibr" rid="R80">80</xref></sup>. (<bold>b</bold>) Schematic of the WASA-1 prophage highlighting <italic>wonAB</italic> and genes with predicted functions in prophage biology. (<bold>c</bold>) Heat-map showing mean PFU/mL of diverse ICP1 isolates determined by plaque assays on Peruvian <italic>V. cholerae</italic> strains in WT and ΔWASA-1 backgrounds, determined as in (<bold>a</bold>). (<bold>d</bold>) Plaque assay showing the effects of ΔWASA-1, Δ<italic>wonAB</italic> and <italic>wonAB</italic> complementation in strain A1552 on ICP1-2006 PFU/mL alongside the effect of producing WonAB in non-WASA strains. (<bold>e</bold>) Replication assay showing change in PFU/mL over time following infection of the indicated A1552 cultures with <italic>c.a</italic>. 10<sup>3</sup>-10<sup>4</sup> PFU of ICP1-2006. (<bold>f</bold>) Plaque assay showing effect of E7946 derivatives producing either WonA, WonB or WonAB on ICP1-2006 PFU/mL. Where indicated, strains in (<bold>d</bold>-<bold>f</bold>) contain a chromosomally integrated transposon carrying the arabinose-inducible <italic>P</italic><sub>BAD</sub>-promoter, induced by the addition of 0.2% arabinose. (<bold>g</bold>) AlphaFold3 predicted structure of the putative WonAB complex shown below schematic (top) indicating the conserved motifs. Residues targeted by site-directed mutagenesis are highlighted in red. (<bold>h</bold>) Plaque assay testing the effect of WonA and WonB site-directed variants expressed from their native locus on ICP1-2006 PFU/mL. Bar charts show the mean + s.d. from 3 independent repeats. d.l. = detection limit.</p></caption><graphic xlink:href="EMS201156-f001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><title>WonAB protects cells by lysis-independent abortive infection.</title><p>(<bold>a</bold>) Growth kinetics of <italic>V. cholerae</italic> strain A1552 in the presence (WT) and absence of WASA-1 (ΔWASA-1), with either no phage or infected at time 0 with ICP1-2006 at the indicated MOI. Data are representative of three independent repeats. (<bold>b</bold>) Time-lapse microscopy comparing exponentially growing cells of <italic>V. cholerae</italic> A1552 WT and ΔWASA-1 strains after infection with ICP1-2006 at MOI 5. (<bold>c</bold>) Fold-change in ICP1-2006 genome copy number relative to time 0, as determined by qPCR, after infection of either WT or ΔWASA-1 strains with ICP1-2006 at MOI 0.1. (<bold>d</bold>) Time-course microscopy snapshots comparing cell morphology and cellular DNA content, as monitored by a HU-mNeonGreen fusion, in WT and ΔWASA-1 backgrounds following infection with ICP1-2006 at MOI 5. (<bold>e-g</bold>) Time-course microscopy snapshots comparing ICP1 capsid assembly, as monitored by the incorporation of a host-cell produced mNeonGreen (mNG) fusion to the ICP1 major capsid protein Gp122 (<bold>e</bold>), in either WT (<bold>f</bold>) or ΔWASA-1 (<bold>g</bold>) backgrounds, following infection with ICP1-2006 at MOI 5. All images are representative of the results of three independent experiments. Scale bars = 5 µm.</p></caption><graphic xlink:href="EMS201156-f002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><title>WonAB activation shuts down cell growth by inhibiting translation.</title><p>(<bold>a</bold>) Toxicity assay evaluating the growth of 10-fold serial dilutions of <italic>V. cholerae</italic> strain A1552 cultures and the indicated derivatives on solid media, in the absence (LB) and presence (+ 0.2% ara) of WonB overproduction. (<bold>b</bold>-<bold>c</bold>) Toxicity assay evaluating the growth kinetics (<bold>b</bold>) and cell viability (<bold>c</bold>) of exponentially growing cultures in liquid media upon WonB overproduction following induction at time 0, as compared to a negative control strain and a strain overproducing the inactive WonB[K71A] variant. (<bold>d</bold>) Time-course microscopy snapshots showing the effect of WonB overproduction on cell morphology and cellular DNA content, as monitored by a HU-mNeonGreen fusion, compared to a negative control strain and a strain overproducing the inactive WonB[K71A] variant. Scale bar = 5 µm. (<bold>e</bold>) Western blot showing protein levels of WonB and WonB[K71A] over time following induction in exponentially growing cells at time 0. Predicted molecular mass of WonB, 16.1 kDa. Sigma70, was used as a loading control (<bold>f</bold>) Western blot showing protein levels of WonB[K71A] over time following induction in exponentially growing cells at time 0, in the absence and presence of chloramphenicol (Cm), added at 15min (T15). (<bold>g</bold>) Western blot showing protein levels of WonB and WonB[K71A] over time following chloramphenicol (Cm) addition, in the presence (<italic>lon</italic>+) and absence of Lon protease (Δ<italic>lon</italic>). Overexpression of genes in (<bold>a</bold>-<bold>g</bold>) was done from a chromosomally integrated transposon carrying the arabinose-inducible <italic>P</italic><sub>BAD</sub>-promoter, induced by the addition of 0.2% arabinose. Charts show mean values, error bars show s.d. All images, charts and blots are representative of the results of three independent experiments.</p></caption><graphic xlink:href="EMS201156-f003"/></fig><fig id="F4" position="float"><label>Fig. 4</label><caption><title>VSP-II<sup>WASA</sup> variant encodes two distinct anti-phage defence systems.</title><p>(<bold>a</bold>) Schematic of VSP-II<sup>WASA</sup> highlighting the LAT-1 variant present in the WASA lineage and the previously characterised DdmABC system. (<bold>b</bold>) Fold-protection against <italic>E. coli</italic> phages of the BASEL collection conferred by the production of the indicated systems and components in <italic>E. coli</italic>, compared to a negative ‘no system’ control. Boxes with a filled dot indicate phages exhibiting altered plaque morphology. Data represent the mean of two independent repeats. (<bold>c, f</bold>) Predicted structures of GrwAB (<bold>c</bold>) and <italic>Vc</italic>SduA (<bold>f</bold>) generated using AlphaFold3 shown below schematics (top) indicating the conserved domains and motifs identified in each system. Residues targeted by site-directed mutagenesis are highlighted in red. (<bold>d, g</bold>) Fold-protection against the indicated <italic>E. coli</italic> phages conferred by site-directed variants of GrwAB (<bold>d</bold>) and <italic>Vc</italic>SduA (<bold>g</bold>) in <italic>E. coli</italic>, compared to a negative ‘no system’ control. Bar charts show the mean + s.d. of three independent repeats. (<bold>e, h</bold>) Growth kinetics of <italic>E. coli</italic> cultures in the absence (No system) and presence of either GrwAB (<bold>e</bold>) or <italic>Vc</italic>SduA (<bold>h</bold>), with either no phage or infected at time 0 with the indicated MOI. Data are representative of three independent repeats. Systems were expressed from a chromosomally integrated transposon using the arabinose-inducible <italic>P</italic><sub>BAD</sub>-promoter. Growth media were supplemented with 0.2% arabinose.</p></caption><graphic xlink:href="EMS201156-f004"/></fig><fig id="F5" position="float"><label>Fig. 5</label><caption><title><italic>Vc</italic>SduA protects <italic>V. cholerae</italic> against <italic>vibrio</italic> phage X29.</title><p>(<bold>a</bold>) Plaque assay showing X29 plaque-forming units (PFU/mL) on the pre-7<sup>th</sup> pandemic strain MAK757, in the presence and absence (Δ<italic>manCB</italic>) of the O1-antigen. (<bold>b</bold>) 10-fold serial dilution plaque assays of X29 on wave 1 <italic>V. cholerae</italic> strains, comparing the effect of deleting <italic>ddmABC</italic> in non-WASA (N16961, P27459, E7946) and WASA-lineage (A1552, C6706) strains, below a pre-7<sup>th</sup> pandemic control (MAK757). (<bold>c</bold>) Plaque assay showing X29 PFU/mL obtained on C6706 derivates deleted for combinations of <italic>ddmABC</italic> with ΔLAT1 (Δ<italic>grwAB</italic>-<italic>VcSduA</italic>), Δ<italic>grwAB</italic> and Δ<italic>VcSduA</italic>, alongside representative images of each 10-fold serial dilution plaque assay. Note that strain C6706 was used in these assays because the rifampicin antibiotic resistance marker in strain A1552 partially interferes with X29 infection. (<bold>d-e</bold>) Plaque assays testing the ability of <italic>Vc</italic>SduA production to complement X29 protection in a C6706Δ<italic>ddmABC</italic>Δ<italic>VcSduA</italic> background (<bold>d</bold>) and in Δ<italic>ddmABC</italic> backgrounds of the non-WASA linage strains E7946 and P27459 (<bold>e</bold>). Bar charts show the mean + s.d. from 3 independent repeats. d.l. = detection limit. Images are representative of the results of three independent experiments.</p></caption><graphic xlink:href="EMS201156-f005"/></fig></floats-group></article>